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Thesis Portfolio Overview 
            This thesis follows the research portfolio format and is carried out in partial fulfilment 
of the academic component of the Doctorate in Clinical Psychology at the University of 
Edinburgh. In two chapters, the portfolio aimed to explore the role of psychological factors in 
asthma morbidity outcomes in adults with asthma. Chapter One includes a systematic review 
of published research literature exploring the relationship between emotion regulation 
strategies and asthma morbidity outcomes in the adult population. Chapter Two presents an 
empirical study examining the role of generalised anxiety in asthma outcomes and how 
experiential avoidance and self-efficacy influence this relationship. Both chapters have been 
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Thesis Portfolio Abstract 
           Despite enhancements in medical asthma treatments, the disparity in asthma outcomes 
remains a pressing issue in asthma care and represents a significant personal burden for 
individuals living with asthma. To further improve available care, it is crucial to better 
understand which psychological factors might account for such disparity and the mechanisms 
through which they operate. In two chapters, the current research portfolio aimed to explore 
the role of psychological factors in asthma morbidity outcomes in adults with asthma.  
           The first chapter is a systematic review exploring the relationship between six emotion 
regulation strategies: acceptance, avoidance, problem-solving, reappraisal, worry/rumination 
and suppression and asthma outcomes: asthma control, health-related quality of life (QoL), 
health care utilisation and medication compliance in adults with asthma. A systematic search 
of four electronic databases resulted in 18 studies which met the inclusion criteria. The 
systematic review highlighted significant relationships between emotion regulation strategies 
and asthma outcomes. The direction of these relationships depended on the type of emotion 
regulation strategy and the asthma outcome studied. Findings from the current review 
highlighted that psychological interventions aimed at promoting more adaptive emotion 
regulation skills in adults with asthma might positively influence their asthma morbidity 
outcomes. Further research is needed, using improved methodological design and a clearer 
conceptualisation of emotion regulation construct. 
            The second chapter presents an empirical study. It explored the role of generalised 
anxiety (GA) in asthma outcomes: asthma QoL, asthma control and short-acting asthma 
reliever medication use (SAARM) and the potential mediation role of experiential avoidance 
(EA) and asthma control self-efficacy (SE). A cross-sectional set of questionnaires was 
completed by 65 participants attending NHS outpatient respiratory clinics. Correlation and 
mediation path analyses were conducted. Higher GA was associated with poorer asthma 
outcomes, lower asthma control SE and higher EA. After controlling for covariates, both SE 
and EA were found to mediate the relationship between GA and both asthma control and QoL. 
Neither SE nor EA played a mediatory role in the relationship between GA and SAARM use. 
These results need to be replicated in research using a longitudinal design. However, they 
provide preliminary support that psychological interventions targeting asthma control SE and 







Layperson summary  
         Despite better available asthma medical care, people vary greatly in how they fare with 
asthma. To further improve available care, it is important to understand which psychological 
factors might influence these differences and how. In two chapters, the current research 
portfolio aimed to explore the role of psychological factors in asthma outcomes in adults with 
asthma.   
 
Chapter one: Systematic review 
         Asthma is a chronic condition which is often linked with life adjustments, difficult self-
management routines and unpleasant physical symptoms which are hard to predict. This can 
cause people living with asthma to experience many difficult emotions. Although the way 
people manage difficult emotions (a concept known as emotion regulation) has been linked 
with poorer illness outcomes in other chronic health conditions, asthma research is lacking.  
          We have reviewed available studies on emotion regulation and asthma outcomes such 
as asthma control, health-related quality of life (QoL), use of health services and use of asthma 
medication as advised. We have specifically looked at 6 common ways to regulate emotions 
such as: accepting, avoiding, reframing them in a positive light (a concept known as positive 
reappraisal), actively trying to approach the problem which causes the negative emotion 
(problem-solving), suppressing and worrying/ruminating (going over negative thoughts in 
one’s head). The review aimed to see whether people who use different ways of regulating 
emotions fare better or worse with their asthma. We looked at studies with adults with asthma 
who were aged 16 and over.  
          The review showed that how people fared with asthma depended on the emotion 
regulation strategy they used. Avoiding, suppressing, and worrying were linked with worse 
asthma outcomes, whilst positively reappraising, accepting and expressing emotions were 
noted in people with better asthma outcomes. The results suggested that treatment supporting 
people with asthma to better manage their emotions might be useful to improve their asthma 
outcomes. We do however need more research to be confident of these findings.  
 
Chapter two: Research study  
          Many people with asthma have generalised anxiety (frequent and uncontrollable worries 
about many different things) and this has been linked to poorer asthma control, poorer asthma-
related QoL and the need to use asthma reliever medication more often. But the reason for this 
link is unclear.  
          In the research study, we tried to find out whether lower confidence in managing asthma 
(construct known as self-efficacy) and greater tendency to cope by avoiding unpleasant 
physical and emotional symptoms (construct known as experiential avoidance) can explain 
how anxiety can lead to poorer asthma outcomes. We were interested in people with asthma 
between 16 and 65 years old who were attending routine NHS asthma clinics. 65 people 
participated in this study. They filled questionnaires that measured levels of generalised 
anxiety, experiential avoidance, self-efficacy and asthma outcomes.  
          The results showed that people with higher levels of generalised anxiety reported poorer 
asthma outcomes. Those with higher levels of generalised anxiety also noted having lower 
self-efficacy to manage their asthma and a greater tendency to use experiential avoidance.  
Lower levels of self-efficacy and higher levels of experiential avoidance were found to 
influence the relationship between higher anxiety and poorer quality of life and asthma control 
but not asthma reliever medication use. These findings could not be better explained by other 
influences such as taking more steroid medication, living with asthma for longer or higher 
reliever medication use. More research is needed to confirm these findings. However, it 
suggests that treatments focusing on self-efficacy to manage asthma and experiential 
avoidance might help improve asthma outcomes in adults with generalised anxiety.  
[5] 
 
Chapter One: Systematic review  
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Abstract 
Aim: The current systematic review aimed to explore the relationship between 
six emotion regulation strategies: acceptance, avoidance, problem-solving, 
reappraisal, worry/rumination and suppression and asthma morbidity 
outcomes (asthma control, health-related QoL, health care utilization and 
medication use) in the adult population with asthma.  Method: A systematic 
search of electronic databases (EMBASE, PsychINFO, PsychARTICLES and 
MEDLINE (through the OVID electronic search interface) resulted in 3615 
studies, of which 18 met the full inclusion criteria. Key information, including 
the relationship between emotion regulation strategies and asthma morbidity 
outcomes were extracted and each study was appraised and rated in terms of 
its methodological quality and risk of bias. Results: The systematic review 
highlighted significant relationships between emotion regulation strategies 
and asthma outcomes. The direction of these relationships depended on the 
type of emotion regulation strategy and the asthma outcome studied. 
Discussion: Findings from the current review highlight that psychological 
interventions aimed at promoting more adaptive emotion regulation skills in 
adults with asthma might be beneficial in improving their asthma morbidity 
outcomes. Further research is needed, using improved methodological design 
and a clearer conceptualisation of emotion regulation construct. 
Keywords: Asthma; health; illness management; quality of life; acceptance; 




1. Background  
 
Asthma is a chronic respiratory illness often characterised by recurrent inflammation 
of airways and physical symptoms such as a tight chest, wheezing, shortness of breath 
and coughing [1]. It is estimated that in the UK 4.3 million adults are currently 
receiving treatment for asthma [2]. Although asthma is a condition that can be 
managed very successfully through self-management and medication, it is estimated 
that in the UK around 1200 people a year die because of asthma [3] and more than 
50% live with asthma which is poorly controlled [4]. Poor asthma control was 
associated with worse outcomes with regards to mortality, asthma-related quality of 
life (QoL) and higher utilization of health services in the UK sample of adult 
[6] 
 
asthmatics [4]. To further improve available care and to reduce the individual and 
economic impact of asthma, it is crucial to better understand factors which might 
account for such disparity.  
            It is well established that chronic illness including asthma is often accompanied 
by on-going health threats, unpleasant physical symptoms, and life adjustments [2,5]. 
Additionally, individuals with asthma are required to adopt complex self-management 
health behaviours which place further demands on their cognitive and emotional 
processing. These include managing the physical symptoms of asthma (e.g. medication 
adherence, health care visits) as well as maintaining positive well-being and QoL [2]. 
The burden of asthma symptoms as well as the self-management demands, often lead 
to increased levels of anxiety, stress as well as other arrays of difficult emotions, which 
are often more prevalent than in healthy adults [2, 7-10]. Psychological factors 
including anxiety and stress have previously been linked to poorer health outcomes in 
chronic illness including asthma [7,11]. However, less is known about underlying 
mechanisms accounting for such relationships.  
          The processes which individuals with chronic health conditions use to regulate 
their emotions has been suggested as one possible mechanism to explain the link 
between negative emotions and disparity in health outcomes [12-13]. Emotion 
regulation is defined as a self-regulatory effort to modulate which emotions we feel, 
when we feel them, how we feel them and express them [14]. It has been suggested 
that illness-related emotional demands can deplete individuals’ resources to self-
manage their illness, intensify, and prolong the experience of physical symptoms 
leading to poorer health outcomes [15-16]. Indeed, research in chronic illnesses such 
as fibromyalgia and cancer found that maladaptive emotion regulation was associated 
with more physical symptoms, higher health care utilization and poorer well-being 
[17-19]. This highlights the importance of exploring processes involved in an optimal 
modulation of responses to difficult emotions to better understand their impact on 
health-related behaviours and health outcomes. It is vital to recognise that optimal 
emotion regulation does not involve erasing difficult emotion or replacing them with 
positive ones. Instead, it requires individuals to adjust their responses to difficult 
emotions in a way that produces more adaptive responses and choices, leading to better 
illness outcomes [20-21].     
           Previous literature on emotion regulation in the chronically ill population has 
mainly focused on exploring its association with health outcomes in conditions such 
as cancer, diabetes, HIV and chronic pain [22-23]. Similar research exploring emotion 
regulation in the asthma population is more limited [22]. Individuals living with 
[7] 
 
asthma and associated difficulties are likely to experience a different type of illness 
stressors in a specific context. This will inherently impact on how individuals regulate 
their affective experiences. Indeed, individuals with asthma were found to use 
strategies to manage their emotions which differed from those with other chronic 
illnesses [24]. This is in line with both the emotion regulation model by Aldao [20] 
and the model of coping [25] which both highlight the context-specific nature of the 
emotion regulation process. Exploring emotion regulation processes specific to asthma 
population is therefore needed to gain more representative account.  
           Concerning the current systematic review, it is important to note that emotion 
regulation as a construct has been described as complex, lacking consistent 
conceptualisation and comprehensive measurement across different studies [26]. 
Emotion regulation also significantly overlaps with other constructs such as coping. 
Although these have traditionally been studied separately, they both highlight the 
crucial role of using controlled set regulatory processes to modulate the frequency, 
magnitude or content of a wider range of affective, behavioural and physical responses 
[e.g. 14,27-28]. Whilst coping mainly focuses on modulating negative affect in 
response to a stressor, emotion regulation is theorized to occur to regulate any type of 
affect in response to any situation [14, 28]. Despite this, coping uses similar 
modulatory processes (cognitive, behavioural, situational and emotional) and can be 
viewed as a subcategory of emotion regulation occurring under stress [29]. The 
conceptual overlap between individual strategies measured by both coping and 
emotion regulation instruments have also been highlighted in previous research 
[20,31]. These strategies include problem-solving, reappraisal, acceptance, avoidance, 
emotional suppression and worry/rumination [20,32].  
            To our knowledge, only one systematic review looked at coping and health 
outcomes in an asthma population. In their review, Barton et al. [24] found that among 
individuals with asthma the use emotion regulation strategy of avoidance, including 
affective avoidance strategy of denial, were associated with higher emergency care use 
and hospitalisations. However, the evidence for these relationships relied only on a 
small subset of studies (n=4) with two of these employing qualitative design. This 
review reported mixed results for the association between avoidance and medication 
adherence. These results were based on a limited number of studies (n=2). One study 
reported that individuals labelled as “deniers” reported more over-use of reliever 
medication and under-use of preventer medication compared to “accepters” and 
“pragmatists”. Individuals reported their medication use to be linked with their styles 
of regulating their emotions. More general avoidance was not found to be associated 
[8] 
 
with medication adherence in the only included quantitative study exploring this 
relationship. Barton et al. [24] concluded that more research is needed to identify 
which emotion regulation strategies are associated with more optimal asthma health 
outcomes. This will inform us which specific components to include and target when 
designing future asthma interventions.  
            Because of this considerable overlap between coping and emotion regulation, 
studying these independently has often been difficult. Given the clear advantages of 
being able to collectively examine different affect regulatory processes across asthma 
research, specific emotion regulation strategies measured by subscales within either 
emotion regulation or coping measures will both be included in the present review. For 
the current review, emotion strategies will be defined as processes through which 
individuals consciously modify the magnitude and/or the type of their emotional 
experience or events which elicited those experiences [30]. The current review will 
focus on six categories of emotion regulation strategies, namely emotion suppression, 
avoidance, acceptance, rumination/worry, a problem-solving and positive reappraisal. 
These categories were reported in a recent systematic review by Aldao et al. [30] and 
were previously theorized to measure overlapping constructs across both coping and 
emotion regulation research [31]. For a definition of these emotion regulation 
categories please see Appendix AA. Although these will provide a helpful framework 
to review relevant emotion regulation strategies, it is important to note that these reflect 
only a small subset of strategies which adults with asthma might employ to manage 
their emotional experiences. The current systematic review will focus on adult asthma 
population to allow comparison with previous systematic reviews.  
    Given the previously highlighted gaps in the emotion regulation literature, the 
current systematic review aims to expand on previous work by synthesising and 
critically appraising research on emotion regulation and health outcomes in adult 
asthma population. Specifically, it will focus on exploring which emotion regulation 
strategies are linked with better/poorer asthma morbidity indicators such as QoL, 









2. Methods  
Search strategy 
A systematic review was conducted in October 2019, searching the following 
electronic databases: EMBASE, PsychINFO, PsychARTICLES and MEDLINE 
(through the OVID electronic search interface). The search strategy used a 
combination of each emotion regulation strategy and type of health outcome in adult 
asthma population. These included the following broad terms and associated MeSH 
subject headings: “accept*”, “avoid*”, “reapprais*”, “suppress*” “problem-solv*”, 
“ruminat*”, “emotion* regulat*”, “emot* dysregulat*, “self-manag*”,“asthma quality 
of life” and “asthma*”. The search was limited to articles published between 1985 and 
2019, available in English or Czech and involving humans. A full search strategy used 
is outlined in Table 1 in Appendix A. The reference list of identified articles was hand 
searched for additional relevant studies. A protocol for the current systematic review 
was registered with the International Prospective Register of Systematic Reviews 




Studies were eligible for inclusion if they reported data regarding a relationship 
between one or more of the following emotion regulation strategies: (acceptance, 
avoidance, problem-solving, reappraisal, rumination, suppression) and at least one of 
the following primary asthma outcomes of interest: self-reported and physiological 
indicators of asthma control, asthma medication adherence and asthma/or health-
related QoL. Studies were defined as assessing an indicator of asthma control if they 
included a validated measure of asthma control (e.g. ACT and ACQ) or measured one 
of the following key expressions of asthma control as defined by Global Initiative for 
Asthma guidelines such as day/night symptoms, physical activity limitations, 
exacerbations, or lung function (measured by e.g. forced expiratory volume in one 
second (FEV1) or peak expiratory flow rate (PEFR) [30]. Study selection was limited 
to studies which employed a validated measure of an emotion regulation strategy, in 
line with specific subscales detailed in a recent meta-analysis by Aldao et al. [30] and 
which were conducted in adults 16+ years old with a diagnosis of asthma. Studies were 
excluded if they only included a general emotion regulation score and data regarding 
specific subscales could not be obtained. Studies addressing both adults and children 
were eligible for inclusion if adult data were reported separately or if the mean age of 
[10] 
 
the recruited sample was at least 16 years.  Studies involving adults with comorbid 
health conditions which may have had influenced their memory, such as dementia and 
Parkinson's disease were excluded. Studies using a population with co-morbid 
substance misuse difficulties were also excluded as substances can act as a form of 
emotion regulation (e.g. experiential avoidance). Single case studies and qualitative 
design studies were excluded. Dissertations, theses, poster presentation and conference 
abstracts were included if they included enough detail about the study methodology or 
further information was obtained from contacting authors or manual searches.  
 
Data extraction and synthesis 
The author (LM) independently examined the search output and screened it by title 
and abstract. Using the outlined inclusion criteria, the full texts of potentially eligible 
studies were retrieved and assessed further for eligibility. Data were extracted from 
eligible studies regarding sample characteristics, emotion regulation strategy 
characteristics, study methods and data on the relationship between specific emotion 
regulation strategy and specific asthma control outcomes of interest. Detailed data 
extraction form can be found in Appendix B. Authors were contacted, where 
necessary, for further information. 
 
Assessment of study quality 
The current review employed the Downs and Black checklist [34] (Appendix C) to 
appraise the methodological quality of the included studies. This checklist has been 
adapted to appraise four areas of methodological quality, specifically: external 
validity, internal validity: bias, internal validity: confounding (selection bias) and 
power. Within these areas, six criteria were considered for each selected study: (i) the 
representativeness of the study sample; (ii) the use and reporting of "data dredging" 
(iii) the appropriate use of statistical tests to assess outcomes; (iv) the appropriate use 
of outcome measures; (v) the adequate adjustments for confounding in the analyses 
from which the main findings were drawn; (vi) the sufficient power of the sample to 
detect clinically significant effects where the reported difference had less than 5% 
probability to occur by chance. Please refer to Appendix D for more details regarding 
the adapted checklist. 
           Using the above criteria, selected studies were rated by the author (LM). A third 
of the included studies were randomly selected to be rated by a second reviewer 
(GOH). A disagreement between reviewers was discussed and resolved by consensus. 
Selected articles were rated according to whether they appropriately addressed (1 
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point) or did not address/unable to determine (0 points) each criterion. A total score 
for each study was then calculated. Scores were used to categorise studies as being of 
good (A), satisfactory (B) or poor methodological quality (C) (Appendix E). 
 
3. Results  
 
Search results 
          The search and the screening procedure identified 18 full-text articles which met 
the inclusion criteria and were eligible for data extraction. See Figure 1 for the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
flowchart [35]. 
 





















The characteristics of eligible articles and key findings are presented in Table 1.1. and 
1.2. respectively. Articles were each assigned a study number. This study number will 
be used to refer to articles in the following sections.   
           One study appeared twice, as each article used different analysis and 
investigated different primary outcomes [S2,4]. Six of the 17 included studies were 
conducted in the USA [S12,13,14,15,17,18], five in Australia [S2/4,3,5,8], three in 
Spain [S7,9,10], two in Netherlands [S6,11] and one study each in Poland [S16] and 









           All studies in the present review were quantitative with a majority using a cross-
sectional design (12 studies) [S1,5,6,7,10,11,12,13,14,16,17,18]. Additional four 
studies were longitudinal [S2/4,9,15] and assessed correlation or similar relationship 
between predictor at baseline and outcome of interest at follow up. In most cases, the 
variables were assessed at 12 months follow up. One study included a control group 
[S8] and one consisted of prospective RCT [S3]. Data regarding a relationship between 
emotion regulation strategy at baseline and primary/secondary outcomes at 12 months 
follow up were extracted from the RCT study.   
           Overall, the 17 studies had a total of 5515 participants (at baseline), where 10 
of these reported <100 participants each.  The sample sizes ranged from 14 to 3496 
participants. Most studies recruited participants who were at least 16-18 years of age 
with a maximum age cut off for participation ranging from 60-75years. Six studies 
included no maximum age criteria for participation [S2/4, 5 14,16,17,18]. The sample 
mean of studies focusing on adults with asthma range ranged between 34.7 – 49 years. 
The broadest age range reported in this review was between 18-89 years [S16]. Two 
studies focused on a younger demographic group of school and college students and 
reported sample mean age between 16.24 – 19.5 years [S6,12].  
           Eight studies in this review recruited subjects from secondary and tertiary 
asthma care settings. Three of these studies included participants attending hospital 
outpatient Immuno-allergy/pneumology [S7,9,10] and pulmonary clinics [S14], 
inpatient wards [S16] or a combination of both [S2/4, 3]. One study employed a sample 
presenting at the Accident and Emergency (A&E) department [S5]. Only one study 
recruited their subjects from Primary care settings, namely GP practices [S11]. Three 
studies employed a community sample of individuals with asthma, two recruited from 
school and university college settings [S6,12] and one study used general asthma 
population [S1]. Study 15 used a convenience sample recruited from public/private 
pulmonary clinic, community chest clinic, general population, and college.  
             Most of the reviewed studies used a validated method to establish an asthma 
diagnosis. These included a diagnosis made by a physician (12 studies) 
[S2/4,3,5,6,7,10,11,14, 15,16,17,18], often in combination with an objective measure 
such as spirometry or PEFR, objective measures such as spirometry or PEFR only [S8] 
and a social insurance register record for an asthma medication reimbursement [S1]. 
One study established asthma diagnosis through a self-report only [S13] and one used 
a combination of a self-report and an asthma screening questionnaire [S12]. Ten out 
of 14 studies included participants with moderate to severe asthma. In 4 included 
studies, the severity of asthma was not reported or indicated [S8,13,17,18]. 
[13] 
 
           6 studies reported exclusion criteria relating to other respiratory, physical illness 
or/and psychiatric comorbidities [S7,9,10,11,14,18], often without giving a reason. In 
adults with asthma approximately 3.4% of 18-54years old and 12% of over 55 years 
old present with physical, psychiatric or other respiratory comorbidities [36]. These 
comorbidities in adults with asthma have previously been linked with poorer health 
outcomes such as asthma control, higher health care utilisation and lower QoL [37]. 
Not considering comorbidities when investigating asthma health outcomes in the 
above studies can be restricting the representativeness and generalisability of the 
recruited samples.  
           In the 18 included articles, the most frequently measured emotion regulation 
strategy was avoidance (reported in 11 studies), followed by problem-solving (8 
studies), acceptance and emotion suppression/expression (measured in 5 studies each), 
positive reappraisal (3 studies) and rumination/worry (2 studies). Selected emotion 
regulation measures varied greatly across studies.  The most employed instrument was 
Coping Orientations of Problems experienced (COPE) questionnaire [38] and Illness 
behaviour questionnaire (IBQ) [39], each used in three studies.    
           Most measured asthma morbidity outcome in this review was asthma control 
(including indicators of asthma control) (10 studies), followed by HRQoL (9 studies), 
























The relationship between emotion regulation (ER) and asthma morbidity outcomes 
 
The following section will examine the relationship between selected ER strategies 
(experiential avoidance/acceptance, problem-solving, positive reappraisal, 
rumination/worry, and emotion expression/suppression) and asthma morbidity 
outcomes.  
 
Emotion regulation and indicators of asthma control 
 
Out of the 10 studies which measured asthma control four used standardised asthma 
control measures [S6, 12, 13,14], four included self-report scales (frequency/severity of 
symptoms) [S1,5,17,18] and two employed objective measure of asthma control (e.g. 
PEFR and FEV1%predicted) [S15,17]. The most frequently used validated 
questionnaires to measure asthma control were Asthma control questionnaire (ACQ) 
[51,53] (2 studies) [S6,14] and Asthma Control Test (ACT) [69] (2 studies) [S12,13]. 
 
Avoidance/Acceptance 
Three studies [S6,12,13] assessed the role of acceptance in asthma control. Two studies 
measured acceptance using the non-judgement subscale of the Five Facet Mindfulness 
Questionnaire (FFMQ) [67] [S12, 13] and one study used the Child and Adolescent 
Mindfulness Measure (CAMM) [51] [S6]. All three studies used a validated self-report 
questionnaire to assess asthma control with two studies utilising Asthma Control Test 
(ACT) [69] [S12, 13] and one study using the Asthma Control Questionnaire (ACQ) 
[53]. All three studies showed that acceptance was not significantly associated with 
asthma control.  
          All three studies were of satisfactory methodological quality with two studies 
[S12, 13] being limited by employing relatively small samples (n = 56, n = 61) 
respectively. Study 12 but not 13 was calculated to have enough statistical power, but a 
larger sample would increase confidence in findings. Studies 13 and 6 were limited by 
using a non-representative non-smoking community sample [S13] and school/college 
students of particular asthma severity (excluding milder cases not taking preventative 
medication) [S6]. The studies also varied in the levels of asthma control represented by 
mean scores ranging from well-controlled [S12], borderline adequately controlled [S6] 
[23] 
 
and poorly controlled [S12]. This makes it difficult to conclude findings across different 
asthma settings and different levels of asthma control.  
          Four studies [S1,5,15,17] looked at the relationship between avoidance and 
asthma control. Three of these studies focused on cognitive avoidance (including 
cognitive denial and mental disengagement) [S1,17,15], three on affective avoidance 
(e.g. denial) [S5,15,17] and two studies [S17,1] included subscales focused on mostly 
behavioural avoidance.  All three studies found that cognitive avoidance was not 
significantly associated with indicators of asthma control measured by self-report 
severity of symptom scale [S1], objective measure of lung function (FEV1%predicted 
and PEFR) [S15,17] and electronic momentary assessment of asthma symptoms [S17].  
          With regards to behavioural avoidance, study 1 found that hiding asthma from 
others was positively associated with poorer asthma control (indicated by higher severity 
of asthma symptoms). In study 17, although greater use of behavioural disengagement 
predicted poorer asthma control in terms of higher severity of symptoms and worse lung 
function (PEFR scores), this link did not reach significance. This study was limited by 
the non-representativeness of the recruited population and by not accounting for 
confounding variables. Although it employed a sample size which had enough power (n 
=61), a larger sample size would increase confidence in the findings.   
            Studies exploring affective avoidance mainly focused on the relationship 
between denial and asthma control [S5, 15, 17]. One study [S17] found that a greater 
tendency to employ denial as an emotion regulation strategy was significantly associated 
with poorer asthma control as indicated by higher asthma symptom severity and poorer 
lung function. A different result was found by two studies [S5, 15] which found a non-
significant correlation between affective denial and asthma control as measured by lung 
function (FEV%pred) [S15] and asthma severity score [S5]. All three studies were of 
satisfactory methodological quality. Limitation of study 17 has been described above. 
Study 15 was limited by a non-representative sample and not controlling for 
confounding variables. Study 5 was limited by employing small sample size with 
insufficient power using a non-validated measure of asthma severity.  
 
Problem-solving 
Two studies explored problem-solving and asthma control [S1,14]. Both studies found 
a significant association between greater problem solving and asthma control. However, 
the direction of this relationship differed across studies. Study 1 found that greater use 
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of problem-solving (strategy of information seeking) was significantly linked to poorer 
asthma control (indicated by higher reported severity of asthma symptoms). Study 14 
found that greater application of impulsive, careless and hurried problem-solving skills 
has been associated with poorer asthma control scores.  
 
Worry Rumination  
Only one study looked at Worry/Rumination and asthma control [S1]. This study found 
that greater asthma worry was strongly associated with poorer asthma control (indicated 
by higher asthma severity) in a sample of hospital outpatients with asthma. This was a 
good quality study with a very large sample drawn from the general population.  
 
Emotion Expression/Suppression 
Three studies looked at the relationship between the use of emotion 
expression/suppression and indicators of asthma control. Only one study explored 
emotion suppression [S18]. This study found that suppressing emotions (anger) was 
associated with poorer control of asthma symptoms as indicated by both higher asthma 
symptoms severity and more physical limitation due to asthma symptoms. This study 
was of good methodological quality. Of note is the high proportion of female 
participants (72%) in the study.  
          Three studies looking at emotion expression found that expression of negative 
emotions (anger) [S18] was not significantly linked to indicators of asthma control 
(asthma severity, function limitation). There were mixed results with regards to a 
relationship between general emotion expression (through labelling) and asthma 
control [S12,13]. Whilst study 13 reported a significant positive relationship with 
asthma control scores, study 12 noted n/s association. Both studies used the same 
measure of emotion expression (FFMQ) and asthma control (ACT).  
           The discrepancy in results might be due to several methodological differences. 
Study 12 included a younger population of Psychology undergraduate students whilst 
study 13 was conducted in a community sample of adults with asthma with a higher 
mean age. Both studies were of satisfactory methodological quality, both limited by 
relatively low sample size. Study 12 was limited by not adjusting for potential 
covariates whilst study 13 used sample with limited representativeness to the target 
population. The two samples also varied in levels of asthma control. Whilst the student 
sample reported well-controlled asthma, the community sample had mean asthma 
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control scores within the poorly controlled range. It is likely that individuals with well-
controlled asthma experience less asthma-related stressors and might have fewer 
opportunities or need to regulate their emotions through expression. Since 
Undergraduate Psychology students by nature are likely to be a relatively homogenous 
group and have more developed skills in and value expressing emotions, findings from 
this study are not generalisable to the wider asthma population.  
 
Positive reappraisal 
Three studies explored whether individuals’ tendencies to regulate their emotions by 
positively reappraising stressful situations are linked with asthma control. Two of these 
studies found that positive reappraisal was not significantly correlated with indicators of 
asthma control as measured by asthma severity scale [S1] and Asthma Control 
Questionnaire (ACQ) [S14]. To strengthen these findings, negative appraisal, which can 
be viewed as the opposite end of the appraisal continuum, was also not significantly 
correlated with asthma control scores [S14]. A different pattern was reported by  [S7] 
who found that less use of positive reappraisal was linked with poorer asthma control 
scores (ACQ).  
            The two studies were both of satisfactory methodological quality. Study 1 
included a very large sample size (n = 3496) and a representative sample drawn from a 
general population of adults with asthma. However, it employed a non-validated self-
rated scale to measure the severity of asthma symptoms as indicators of asthma control. 
Study 14 showed some methodological limitations such as inadequate sample size (n = 
44) and less representative sample (excluding milder cases of adults with asthma who 
did not report asthma medication use). These studies also varied in terms of asthma 
context. Study 1 recruiting participants from the general population with a mean asthma 
control of the sample indicative of mild (well-controlled asthma). Whilst the sample 
recruited by study 14 and study 7 were drawn from the same data set and included 
hospital outpatients with higher asthma severity.   
           Therefore, the evidence from study 1 carries higher weight and increases 
confidence in the above findings. However more well powered and representative 






Emotion regulation and health-related quality of life (HRQoL) 
 
Seven out of nine studies looking at HRQol employed asthma specific HRQoL 
measures. Only 2 studies employed the same instruments to measure HRQoL, namely 
mini Asthma Quality of Life Questionnaire (AQLQ) (asthma specific measure) [56] 
[S7,14] and Short-Form Health Survey (SF-36) (general measure) [48] [S4,10]. 
 
Avoidance  
Four studies explored the relationship between avoidance and HRQoL [S1,4,10,11] with 
two studies exploring multiple aspects of avoidance [S1,4]. Four studies which 
employed subscales focusing on a cognitive-behavioural aspect of avoidance found that 
it was linked to poorer asthma HRQoL outcomes [S1,4,10,11]. This was the case for 
both asthma specific [S4,11] and general aspects of HRQoL [S4,10,1].  
           All three studies were of good to satisfactory methodological quality and 
employed relatively large sample sizes with a study 1 employing a notable sample size 
of 3496 participants. One of these studies focused on general population [S1], one 
included primary care patients with milder asthma severity [S11], whilst the remaining 
two explored hospital outpatient population with higher asthma severity [S4,10]. This 
suggests that the impact of avoidance on HRQoL might not necessarily be influenced 
by the severity of asthma. One study which focused on denial, an affective dimension of 
avoidance found that this style of ER was not significantly associated with neither 
asthma specific nor general HRQoL [S4].  
 
Problem-Solving  
Five studies looked at problem-solving and HRQOL [S1,4,10,11,14]. Two studies found 
a positive relationship between greater use of problem-solving and a better asthma 
specific [S4,14] and general HRQOL [S4], whilst one study [S1] found that greater 
problem-solving was linked with poorer Physical domain of HRQoL. Study 1 and 4 
looked specifically at information seeking and information seeking and planning 
respectively.  In study 4, baseline PS scores were linked to a better HRQoL on both 
asthma specific and general measures at baseline. However, this association remained 
significant only for the physical aspect of general HRQoL at 12month F/U. 
           In contrast, two studies [S10,11] found no significant relationship between 
problem-solving and HRQoL. Both studies [S10,11] employed relatively large samples 
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and were of satisfactory methodological quality. However, compared to other studies, 
study 11 used a sample of primary care asthma population characterized by less severe 
asthma. It is also important to note that a high proportion of a recruited population (66%) 
in study 10 reported well-controlled asthma. It is possible that a population with less 
severe and better-controlled asthma, are exposed to less asthma-related stressors and 
experience less negative affect. These individuals might have less need or opportunities 
to employ problem-solving skills to regulate difficult emotions. Another reason for the 
disparity in findings across studies could be due to different aspects of problem-solving 
measured. Whilst study 1 and 4 specifically focused on information seeking aspect of 
problem-solving, study 10 and 11 included more general problem-solving measures.  
 
Rumination/Worry 
Only two studies explored the emotion regulation strategy of worry with HRQoL in 
asthma patients. Both studies found that the tendency to employ worry to cope with 
difficult emotions was linked to poorer asthma specific [S7] and general HRQoL [S1]. 
These studies were of good [S1] and satisfactory methodological quality [S7].   
 
Positive reappraisal 
Only one study explored positive reappraisal and HRQoL and found that, amongst the 
general asthmatic population, greater use of positive reappraisal was associated with 
better general HRQoL [S1]. This was a good quality study with a large sample. 
 
Emotion suppression/expression 
Only one study [S12] explored the relationship between emotion expression and 
HRQoL. It reported that in the community sample of adults, greater use of expressing 
emotions by describing was associated with better asthma specific HRQoL (higher 
AQLQ scores). This study was of satisfactory methodological quality, limiting its 
sample representativeness by excluding smokers and having a small sample size. Its 








Emotion regulation and health care utilisation (HCU) 
 




One identified study [S9] looked at the relationship between acceptance and HCU. It 
found that lower acceptance scores were associated with a higher number of 
hospitalisations in the past 3y, HCU index, home visits, phone consultations and district 
nurse interventions. Acceptance was not significantly associated with a frequency of 
A&E visits. 
          Five studies explored avoidance [S1,2,3,5,9]. Three studies explored the use of 
general avoidance as a strategy to regulate emotions (cognitive and behavioural 
elements) [S1,2,9] and 4 specifically looked at the use of denial [S2,3,5,9]. 
           Two out of the three studies looking at general avoidance strategies found that 
neither were significantly associated with indicators of HCU. In study 9 the strategy of 
distraction at baseline was not significantly associated with the frequency of self-
reported A&E visits in the past 12 months. Other avoidance strategies of hiding and 
ignoring were also not significantly associated with HCU, specifically with asthma-
related GP and nurse visits in the past 12 months [S1].  
        Different results were reported by study 2, which found that those who used less 
avoidance at baseline were less likely to be admitted to hospital due to asthma, have less 
repeated hospital admissions (defined as having more than 2) and less repeated A&E 
admissions at 12 months follow up. Compared to study 9, which employed hospital 
outpatients, study 2 employed a population with higher asthma severity and used a 
sample of both hospital outpatients and inpatients including those attending A&E. Study 
2 also recruited subjects with respiratory and other comorbidities, whilst these were 
excluded from study 9. These methodological disparities might account for the different 
finding regarding A&E visits.   
           Three of the studies looking at denial and HCU employed longitudinal design and 
looked at denial at baseline and indicators of HCU at 12 months F/U [S2,3,9]. One study 
was cross-sectional and looked at baseline denial and baseline recall of HCU 1 months 
and 12 months before a near-fatal asthma attack [S5]. Four studies [S2,3,5,9] looking at 
A&E visits reported mixed findings. Study 3 and 9 found that denial at baseline was 
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associated with A&E visits at 12 months follow up. Denial was not associated with A&E 
visits in 2 studies [S2, 5].   
          Three out of 4 studies looking at denial and hospitalisations, found a non-
significant link [S2,3,5], whilst study 9 found a positive correlation. Study 5 found a 
non-significant relationship between denial and ICU admissions 12 months before near-
fatal asthma attack and between denial and doctor's visits 1 month before near-fatal 
asthma attack. 
           In addition to some of the methodological aspects described above, some 
disparities in findings might be due to differences in the denial measures employed. 
Study 2,3 and 5 employed the same measure of denial, namely Illness Behaviour 
Questionnaire (IBQ) [39], whilst study 9 employed the denial subscale of COPE [38]. 
Study 2 and 5 both employed samples with patients with severe asthma whilst 3 and 9 
included sample with moderate and moderate to severe respectively. Study 2, 3 and 5 
were all conducted in Australian’s teaching hospitals with study 2 and 3 conducted by 
the same research group and study 3 and 5 being conducted in the same hospital. Study 
9 was conducted in Spain which might present a difference with regards to cultural and 
contextual factors. Study 9 also employed hospital outpatient sample only, compared to 
study 2,3 and 5 which recruited their samples from both outpatient and inpatient hospital 
settings and study 2 and 5 also including those presenting at A&E. Study 5 employed 
those who presented at A&E with nearly fatal asthma attack which might present 
individuals with a unique life stressor compared to the remaining studies. Study 2 was 
of good methodological quality. Study 3 and 5 were rated as satisfactory with regards to 
a risk of bias, whilst study 9 was rated as being of poor methodological quality. 
 
Problem-Solving  
Two studies explored the relationship between problem-solving and HCU [S1,2]. Both 
studies found that problem-solving was associated with higher HCU. However, the 
direction of this relationship differed. Whilst in study 2, greater baseline problem-
solving score was correlated with less GP and nurse visits [1] less repeated (>2) A&E 
visits at 12 months F/U, study 1 found that greater problem solving (information-seeking 
strategy) was linked with higher  HCU in the past year. Both studies were of good 
methodological quality. Due to the cross-sectional nature of study 1, which makes it 
difficult to identify the direction of the relationship that the results might also mean that 




In one good quality study [S1], greater asthma worry was associated with a higher 
frequency of both GP and nurse visits in the past 12 months. 
 
Positive reappraisal 
Two studies explored whether positive reappraisal is associated with HCU [S1,9]. Both 
studies found a non-significant relationship between positive reappraisal and HCU, 




The only identified study [S9] which explored emotion expression, found that it was not 
significantly associated with HCU, namely frequency of A&E visits at 12 months follow 
up. This study was of poor methodological quality, limited by the representativeness of 
the recruited population, inadequate power, and lack of adjustment for confounding 
variables. 
 
Emotion Regulation and Medication adherence 
 
Avoidance 
Three studies explored the relationship between avoidance and medication adherence 
[S7,8,15]. One study (S8) focused on general avoidance (cognitive, behavioural and 
affective components), whilst two focused on affective avoidance, specifically the 
strategy of denial.  
          Both studies found that greater use of denial was significantly associated with 
poorer adherence with asthma medication [S7,15]. However, in S15 this was only the 
case for affective denial and not cognitive denial. Although the association between 
cognitive denial and medication adherence did not reach significance, it was reported 
that individuals in the suboptimal compliance group had significantly higher total 
cognitive denial scores. Studies differed in the type of medication explored. In study 7 
authors looked at adherence with prescribed corticosteroids whilst study 15 used an 
objective micro-electronic monitor to measure compliance with inhaled controller 
medication (non-specified).  Both studies [S7,15] were of satisfactory methodological 
quality. Study 15 was limited by insufficient power, but its relative strength was 
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employing an objective measure of adherence which introduces less bias due to poor 
recall of symptoms. More studies with adequately powered samples are needed to see 
whether the non-significant result for cognitive denial was influenced by a lack of power 
and to gain more trust in findings regarding the affective denial. 
          Study 8 found a non-significant relationship between general avoidance and 
medication adherence in asthma patients. This study included a wider range of controller 
medication such as theophylline, corticosteroids, beta-antagonists and other preventative 
agents). In study 8, asthmatic patients reported experiencing a high level of medication 
side effects and these have emerged as a unique significant predictor of compliance in 
regression analysis. It is possible that when medication side effects are prevalent, these 
might take precedence as a variable predicting poor compliance over denial. However, 
this study was of poor methodological quality and findings were based on a limited 

























This was a broad systematic review aimed at exploring how the emotion regulation 
strategies utilised by adults with asthma influence their asthma morbidity outcomes. 
Specifically, it focused on the following outcomes: HQoL, health care utilisation, 
medication adherence and markers of asthma control. As previously highlighted the 
research into the relationship between emotion regulation strategies and the selected 
asthma morbidity indicators has been lacking. This was evident by the limited number 
of studies retained in the current review which looked at each strategy and outcome of 
interest. Those studies included often shared common methodological limitations such 
as representativeness (10/18 studies) of included samples, failure to explore potential 
confounding factors and to include these in analyses (8/18 studies) and lack of power 
(7/18 studies).  
            Taking into consideration the methodological limitations, the current systematic 
review highlighted several interesting findings.  
 
The relationship between emotion regulation strategies and asthma morbidity 
outcomes.  
 
The review highlighted significant relationships between emotion regulations strategies 
viewed in the literature as adaptive (acceptance, positive appraisal, emotion expression) 
and better asthma morbidity outcomes. It also found that greater use of strategies 
previously described as maladaptive (avoidance, emotion suppression and worry) was 
linked with poorer asthma outcomes. The role of these depended on the specific emotion 
regulation strategy and morbidity outcome studied.  
 
Emotion regulation strategies associated with poorer asthma morbidity outcomes 
 
The results from the review provided some preliminary evidence that increased use of 
avoidance and worry as strategies to regulate difficult emotions were associated with 
poorer HRQoL in adults with asthma. This evidence was based on studies of good to a 
satisfactory quality.  
           Avoidance was consistently related to HRQoL across all included studies (n =4) 
with samples drawn from a variety of asthma settings suggesting that it might be a factor 
influencing HRQoL despite someone’s severity of asthma symptoms.  The findings are 
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specific to the cognitive and behavioural aspects of avoidance and are in line with 
research from other chronic illnesses such as cancer [83-85].  
          The findings regarding worry and HRQoL are in line with research studies in 
other chronic health conditions such as diabetes and cancer which showed that increased 
illness worry was linked with poorer HRQoL [85]. Previous evidence suggested that 
using worry to regulate emotions might result in individuals getting enmeshed with 
difficult emotions, which further increases their duration and intensity [86]. This is 
likely to influence their adjustment to illness and quality of life [86-87]. Evidence for 
the association of worry and HRQoL were based on a small number of studies (n=2). 
Although these were of good to satisfactory methodological quality, more studies are 
needed to confirm these findings. 
          The systematic review highlighted that greater use of avoidance, suppression of 
negative emotions and worry showed most consistent associations with poorer 
indicators of asthma control (higher severity of symptoms and physical limitations due 
to symptoms).   
          This evidence is specific to the use of behavioural avoidance and was based on a 
limited number of studies (n=2). Cognitive avoidance was consistently non-significantly 
associated with asthma control and evidence regarding the role of denial showed mixed 
results. The role of worry was based on one methodologically strong study. These 
findings are also consistent with extensive research showing that avoidant behaviour 
and worry negatively influences illness control in the chronic population [88-89]. 
   The findings are also in line with an extensive body of previous research which 
suggests that the suppression of negative emotions including anger have been connected 
with poorer physical health across chronic illness population with coronary heart 
disease, rheumatoid arthritis and cancer [90-92]. One explanation is the lingering nature 
of suppressed emotions which can build up over time and resurface with higher 
intensity. The continuous suppressing efforts can then deplete self-regulatory processes 
needed to engage in other tasks such as self-management and engagement with valued 
activities [93].    
            The role of positive appraisal showed mixed findings and more studies with 
higher methodological quality are needed to replicate findings using consistent asthma 
control measures.  
           Some preliminary evidence suggests that avoidance, specifically affective 
avoidance strategies such as denial were linked with poorer adherence with asthma 
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medication. However, only a small number of studies explored this relationship (n=3) 
and more studies are needed to confirm these findings. The evidence between denial and 
medication adherence is in line with research looking at patients with cardiovascular 
disease and HIV [94-95].  
           People with the tendency to employ denial are likely to minimise the seriousness 
of their asthma and be less aware of associated risks to their well-being. This is likely to 
influence their motivation to comply with medication regimens to manage their illness 
[95]. Some preliminary evidence from this review showed that affective rather than 
cognitive elements of denial are associated with poorer medication adherence. It might 
be that an individual’s tendency to deny emotional experiences such as anxiety might be 
a more important factor in adherence as some level of for example anxiety can aid 
motivation to engage in health behaviours.   
          Overall, avoidance was the only emotion regulation strategy studied with regards 
to medication adherence. Given the importance that compliance with asthma medication 
has on asthma outcomes such as quality of life, HCU and asthma control, further 
research should emphasise exploring its correlates. Future studies would benefit from 
more consistent operationalization of denial.  
          Preliminary results from one good quality study suggest that greater asthma worry 
is linked with higher HCU, specifically higher frequency of both GP and nurse visits in 
the past 12 months. This is consistent with previous research on illness worry and HCU 
[e.g. 96]. More studies are needed to confirm these findings.  
 
ER associated with better asthma morbidity outcomes 
 
The systematic review showed some preliminary evidence that greater use of, positive 
reappraisal, emotion expression by describing and acceptance were linked to better 
HRQoL scores. Emotion expression was linked to better asthma control. 
            The findings regarding the adaptive role of positive reappraisal in HRQoL are 
consistent with previous research in both healthy and chronically ill population which 
linked reappraisal with better physical and psychological wellbeing  [92,97]. Previous 
research suggested that positive reappraisal is likely to influence HRQoL by decreasing 
the negative impact of difficult emotions [98]. 
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         The findings are also consistent with previous evidence which found that emotion 
expression by describing was correlated with HRQoL and asthma control in both general 
and chronic health population [99-101].  
         It was suggested that those who can describe their emotions are more likely to have 
an increased understanding of their emotional experiences and be able to effectively 
communicate these to others [68]. This can lessen the emotional intensity of these 
experiences and their potential to drive unhelpful behaviour which can negatively 
influence both HRQoL and asthma control [102]. It is also possible that those who can 
identify and describe their emotions to others more readily have a higher chance of 
receiving more social and health care support and getting their needs met. This is likely 
to positively impact on their well-being and symptom control. 
         However, the evidence for both positive appraisal and emotion expression was 
based on only one study for each asthma outcome and more evidence is needed regarding 
these factors in asthma population. 
          Some preliminary findings regarding the positive role of acceptance on HRQoL 
(n=3) were consistent with previous evidence suggesting that acceptance skills might 
positively influence once well-being through non-judgmentally appraising the impact of 
their asthma symptoms on daily life [103].  
           It was also previously suggested that although acceptance influences appraisal of 
symptoms it is less orientated towards goal-directed behavioural change. As such it is 
less likely to influence actual self-management behaviours and physical symptoms 
[103].  This might explain why acceptance has previously been shown to correlate with 
HQoL but not asthma control of symptoms [103]. This was also the pattern found in the 
current systematic review where acceptance was consistently non-significantly 
associated with asthma control. This evidence for acceptance included consistent 
outcome measures of asthma control (ACT/ACQ), which allowed for a better 
comparison of findings 
         We have found non-conclusive results regarding a relationship between problem-
solving and HRQoL, with a mixture of positively (n=2) negatively (n=1) and non-
significantly (n=2) correlates studies. Studies explored different aspects of problem-
solving and used a variety of measures which made it difficult to summarise findings. 
          Neither Positive reappraisal nor emotion expression was found to be significantly 
correlated with HCU. Given the small number of studies, the poor methodological 
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quality of the majority of these, and the fact that different HCU indicators were measured 
for positive reappraisal, conclusions cannot be made regarding these associations. 
 
Limitations and future direction  
 
The results from the current systematic review need to be considered in light of several 
limitations. Due to a lack of access to translation resources, only articles published in 
English and Czech were considered for inclusion in this review. Since no eligible studies 
were identified in Czech, this review relied solely on studies published in English.  
          Although the current systematic review applied specific criteria regarding the 
inclusion of specific emotion regulation strategies based on previous research (e.g. 30), 
given the review’s complexity and overlapping nature of some constructs, a degree of 
selection bias might have potentially been introduced. The decision to combine emotion 
regulation strategies and coping strategies could also be regarded as a limitation as these 
might differ slightly in the way they are conceptualised. However, at the strategy level, 
both concepts measure how individuals consciously employ efforts to regulate difficult 
emotions, which was the focus of this review. Conducting a broad emotion regulation 
review has advantages of highlighting universal patterns across the available evidence 
base.          
            The variability of measures identified within the current review highlighted that 
future research would benefit from a better operationalisation of emotion regulation 
strategies and consistency in employed measures. This would enable better comparison 
of findings across studies.  
          Due to the limited research looking at emotion regulation strategies and asthma 
outcomes in adults, the current review included studies with a wide range of study 
designs, measurement tools and a heterogenous asthma population with different disease 
severity in various asthma settings. These individuals are likely to face different asthma 
specific challenges and experience different frequency and intensity of situational 
stressors. These are factors which are likely to impact on individuals’ emotional 
responses and the type of emotion regulation strategies they will use to manage these. 
This has made it more difficult to compare findings across studies.  However, there are 
many challenges which asthma individuals have in common such as on-going strain 
related to self-management regimens, increased risk of psychological difficulties such 
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as anxiety and low mood, daily restrictions and experience of unpleasant and often 
unpredictable asthma symptoms [2,5]. 
            Majority of included studies did not consider physical and psychological 
comorbidities which are common in clinical practice and likely to influence both 
emotion regulation and asthma outcomes. These methodological issues were likely to 
limit the internal and external validity of the studies and influence review findings. It 
was previously suggested that individuals with anxiety and low mood often have 
attention and cognitive biases towards more threatening and negative information in 
their environment [104]. These biases can make it more difficult to employ some of the 
emotion regulations strategies such as positive reappraisal which requires individuals to 
shift their attention to more positive information in their environment and/or evaluate 
events in a more positive light.   Similarly, individuals with anxiety and low mood might 
have a lower self-regulatory capacity to employ more cognitively focused strategies 
such as problem-solving [105]. Therefore, future studies should assess how these co-
morbidities influence the use of specific emotion regulation strategies and their impact 
on asthma outcomes. 
            The current systematic review employed a modified quality assessment tool to 
assess the methodological quality of the included studies, which has not previously been 
validated. This can limit the reliability and validity of quality appraisal. However, the 
checklist was based on a Downs and Black’s checklist [34] which has previously shown 
to be a valid and reliable tool to utilise in systematic reviews [34, 106]. A proportion of 
the full-text articles were rated by a second reviewer, with inter-rater checks producing 
a high degree of agreement. This was likely to strengthen the reliability and validity of 
the methodological quality ratings by reducing subjective rating bias.  
                   Due to the cross-sectional nature of many included studies, causal 
inferences could not be made about the found associations between emotion regulations 
strategies and asthma outcomes. For the same reason, the direction of these relationships 
could not be determined. For example, a more effective emotion regulation skills might 
result in better HrQoL, but it might also be that a better HQoL might make it more likely 
for someone to employ more effective regulation skills.  
       The current review was also limited by a small number of studies included for each 
combination of emotion regulation strategy and asthma morbidity outcome.  
[38] 
 
        Further studies should address methodological limitations highlighted in this 
review and employ longitudinal design to help clarify the direction of reported 




The current systematic review highlighted those specific strategies which were linked 
with better asthma morbidity outcomes. It also suggested that certain strategies might 
be more beneficial when considering different asthma outcomes. This might inform the 
design and tailoring of psychological interventions to support adults with asthma who 
have difficulties regulating their emotions. In particular, acceptance-based interventions 
such as the ACT or Mindfulness-based interventions might be beneficial to foster better 
HRQoL, whilst interventions such as CBT might help individuals with asthma to learn 
skills in cognitively appraising their problems, learn skills to cope with worry and target 
avoidance, to improve their asthma control, HCU and medication adherence [107-108]. 
However, further research is needed to evaluate these interventions in asthma patients, 
focusing on specific emotion regulation strategies and asthma morbidity outcomes. 
Creating asthma services which highlight emotional experiences as a crucial part of 
asthma care can reduce some stigma regarding the expression of emotions. Clinicians 
modelling or encouraging emotion expression might benefit patients who tend to control 
or suppress their emotions. Most psychological interventions focus on helping 
individuals to increase awareness of their emotions and support them to learn skills in 
expressing and labelling their experiences. This can improve outcomes in patients with 
asthma in terms of their health outcomes. Educating families of patients with asthma 
about the importance of fostering emotion expression might also enable them to better 




Findings from the current review highlighted that psychological interventions aimed at 
promoting more adaptive emotion regulation skills in adults with asthma might 
positively influence their asthma morbidity outcomes. Further research is needed, using 
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Abstract 
Objective: Although generalised anxiety (GA) has a substantial influence on asthma 
outcomes, the underlying mechanisms remain unclear. This study examined 
individuals’ Self-efficacy (SE) to manage asthma and tendency to avoid unpleasant 
internal states (Experiential Avoidance) (EA) as potential mechanisms that mediate 
the relationship between GA and asthma outcomes: Asthma Quality of Life (QoL), 
Asthma Control and Short-acting asthma reliever medication (SAARM) use. 
Methods: Data were obtained from the NHS Outpatient Respiratory clinic setting 
and included 65 adults with asthma. Path analysis was used to examine mediating 
effects. Results: After controlling for covariates, it was found that both SE to control 
asthma and EA mediated the relationship between GA and both asthma control and 
asthma QoL. Neither SE to control asthma or EA played a mediatory role in the 
relationship between GA  and SAARM. Conclusions: The results provide 
preliminary support for the use of psychological interventions targeting individuals’ 
SE to control their asthma and EA to improve asthma control and QoL in adults with 
asthma and co-morbid GA.   
Keywords: generalised anxiety; experiential avoidance; self-efficacy; asthma; 
quality of life; asthma control 
 
1. Background 
Asthma is a long-term health condition which is caused by obstruction of the airways 
due to inflammation [1]. Even though asthma symptoms can be managed very 
successfully through self-management and medication, it is estimated that in the UK 
around 1200 people a year die because of asthma [2] and more than 50% live with 
asthma which is poorly controlled [3]. Poor asthma control in adults was associated 
with worse outcomes with regards to mortality, asthma-related quality of life (QoL) 
and higher utilization of health care services [3]. This highlights the need for a better 
understanding of factors that hinder effective asthma control and QoL to reduce 
unnecessary asthma-related personal/economic burden and mortality.  
[46] 
 
            In recent years it has become apparent that psychological factors can explain 
an important proportion of variance in asthma outcomes [4,5]. Generalised anxiety 
(anxiety characterized by the presence of unspecified, frequent and uncontrollable 
worries) (GA) has shown to be particularly prevalent in this population compared to 
individuals without asthma diagnosis [6,7]. Higher levels of GA have been linked to 
poorer asthma outcomes such as asthma control, diminished asthma-related QoL and 
higher use of health care utilization [4,8,6].  
            Despite the evidence that GA can lead to poorer asthma outcomes, less is 
known in the literature about the underlying mechanism which can explain this 
relationship. One proposed pathway for the potential effect of psychological factors 
such as anxiety on asthma outcomes is through its effects on self-management and 
health behaviours [9]. Two psychological mechanisms which warrant more 
investigation include experiential avoidance (EA) and self-efficacy (SE). These 
concepts are commonly reported in subjects with high anxiety and have previously 
been linked to poorer health outcomes and self-management behaviours. Looking at 
psychological mechanisms is advantageous as these are amendable through simple 
psychological interventions.  
            EA is emotion regulation style defined by a tendency to control or avoid 
unpleasant internal experiences (including feelings, thoughts and physical sensations 
[10]. It was previously indicated that individuals with GA have a lower ability to 
regulate unpleasant internal experiences and are more likely to engage in EA [11-13]. 
EA has shown to be associated with poorer self-management behaviours such as 
medication compliance and poorer disease control in chronic illnesses such as HIV and 
diabetes [14,15]. Avoidance of internal experiences has also been repeatedly 
associated with worse well-being and QoL in chronic health population [e.g. 16, 17].  
           One proposed mechanism in the literature suggests that in individuals with 
anxiety, EA leads to an increase in the frequency and intensity of suppressed internal 
experiences and their emotional, cognitive and physiological impact [18-20]. A 
prolonged effort and focus on avoiding and controlling negative internal experiences 
are likely to lead to a depleted cognitive, attentional and emotional resources which 
are needed to successfully self-manage illness and make appropriate behavioural 
choices [21].   
          Self-management behaviours in asthma might also trigger distressing illness-
related thoughts and feelings for patients. In individuals with higher EA, this might 
[47] 
 
result in the avoidance of self-management regiments or the use of unhelpful short term 
relieve strategies [22,23]. Previous research showed that psychological interventions 
targeting EA led to an improvement of self-care in other chronic health conditions such 
as diabetes [24,25]. 
            This suggests that affective regulatory processes such as EA should be 
considered as an important factor influencing the relationship between distress and 
health outcomes. Despite this evidence, no published study to date has explored 
whether high levels of EA avoidance influence the relationship between levels of GA 
and asthma outcomes. Also, a large body of existing evidence looking at EA in other 
chronic health population has been limited by employing the Acceptance and 
Commitment Questionnaire (AAQ-I) [17] and revised AAQ-II, [26] widely criticised 
for its poor psychometric properties and discriminant validity [27-29]. Further 
investigations using an alternative measure of EA is warranted to confirm previous 
findings. 
           Another important factor that may also partially explain the link between 
anxiety and asthma-related outcomes is the individual's perceived ability to manage 
their asthma, construct known as self-efficacy (SE) [30]. In individuals with asthma, 
co-morbid anxiety might reduce their confidence and perceived control over their 
symptoms, negatively influencing their SE to self-manage their asthma. Indeed, a 
previous study by Lavoie et al. [6] found that amongst individuals with asthma, higher 
levels of GA were associated with lower self-reported asthma-related SE. Asthma-
specific SE is then a well-established factor associated with worse overall asthma 
control, greater frequency of using a short-acting reliever medication and poorer 
asthma-related QoL [6, 31-34]. However, to date, there is a lack of understanding in 
the literature regarding SE as a potential factor influencing the relationship between 
GA and poor asthma morbidity.  
           The current study was conducted to address some of the gaps in the previous 
research literature by investigating the relationship between GA and asthma morbidity 
indicators (asthma control, use of reliever asthma medication, asthma QoL) in adults 
with asthma and whether individuals’ SE and EA mediate this relationship. The current 
study also tried to address previous methodological limitations by employing more 
recently developed Brief Experiential Avoidance Questionnaire (BEAQ) [10] as a 
measure of EA. This measure has shown good psychometrics and thus might represent 
a more suitable measure to address AAQ limitations. 
[48] 
 
We hypothesise that:   
(1)  In adults with asthma, higher levels of generalised anxiety (GA) will be associated with  
a) poorer asthma morbidity indicators (asthma control, use of reliever asthma 
medication and asthma quality life),  
b) lower Self-efficacy to manage asthma and  
c) greater Experiential Avoidance.  
 
(2) In adults with asthma Self-efficacy (SE) and Experiential Avoidance (EA) will mediate 
the  relationship between: 
a) generalised anxiety and asthma control 
b) generalised anxiety and the use of reliever asthma medication and 
c) generalised anxiety and asthma quality life. 
 
The project intends to benefit clinical practice by increasing our current understanding 
about psychological mechanisms which can potentially be targeted to improve asthma 
outcomes such as asthma control and asthma QoL. More comprehensive interventions 
will directly benefit NHS by reducing costs associated with poorly controlled asthma 



















Participants were recruited consecutively from the respiratory outpatient hospital clinics 
at NHS Fife and NHS Greater Glasgow and Clyde if they met the following inclusion 
criteria: age 16 – 75 years, confirmed diagnosis of asthma without other illness 
presenting higher morbidity, treated for asthma for at least the last 6 months, good 
written and spoken understanding of English language. Patients were made aware by 
screening clinicians as well as in the patient information sheet that they are not eligible 
to take part in the study if they self-report to currently experience episode of serious 
mental illness such as psychosis, currently misusing alcohol or drugs or having a 
diagnosis of fibromyalgia. An acute episode of psychosis, as well as on-going substance 
misuse, were excluded due to its potential confounding influence on the perception of 
symptoms, recall of information as well as self-management behaviours. Participants 
were made aware by screening clinicians as well as in the study information sheet that 
they can still participate in the study before the end of the study date if their situation 
changes. Comorbid fibromyalgia in adults with asthma can lead to reduced 
cardiorespiratory fitness, altered perception of airway obstruction and increased 
hyperventilation [34b]. Therefore, in this study adults with asthma with co-morbid 
fibromyalgia were not eligible to take part to account for its potential confounding 
influence on the severity of respiratory symptoms unrelated to asthma disease. 
2.2. Power and sample size 
The calculation of a sample size needed to detect conditional indirect effects in 
mediation analyses is complex and research into this has been lacking [35]. Per 
recommendations by Fritz & MacKinnon [36], it has been estimated that for mediation 
analyses a sample size of 71 will achieve a power of .8 to detect a medium effect size 




The study received NHS Ethical approval from the Yorkshire & The Humber - Leeds 
West Research Ethics Committee; reference number: 18/YH/0385 (Appendix G). 
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Eligible participants were identified by their current respiratory clinician during a 
routine outpatient appointment. Participants who were eligible and expressed a 
preliminary interest were provided with a study pack which included further information 
and questionnaires to complete. Participants were given a choice to complete the study 
pack in the hospital and return it to their clinician or to take it home and post it back 
using the enclosed pre-paid envelope. Participants were offered to be included in a prize 
draw to win one of two £50 high street vouchers as an incentive for their participation. 
Participants were recruited between 04/02/2019 and 21/02/2020. 
Study pack design 
The study pack can be seen in Appendix L. It included a participant information sheet, 
consent form, demographic questionnaire, six questionnaires assessing psychological 
factors and asthma outcomes and a debriefing sheet.  
Measures 
Generalised Anxiety (GA) 
Generalised Anxiety Disorder Questionnaire (GAD-7) [37] is a widely used and 
validated measure assessing the severity of anxiety symptoms.  The total score ranges 
from 0 to 21, with a score ≥ 10 used as a cut-off indicating the presence of anxiety 
disorder [37-38]. Scores ≥ 5, ≥ 10 and ≥ 15 indicate mild, moderate and severe anxiety 
levels respectively. GAD-7 showed to have an excellent internal consistency (α = .92) 
and good test-retest reliability (ICC = .83) [37]. This was replicated in the current sample 
with GAD-7 showing excellent internal consistency with Cronbach’s alpha. α =94.  
Experiential avoidance (EA) 
Brief Experiential Avoidance Questionnaire (BEAQ) [10] is a 15-item validated 
measure assessing EA – defined as an emotion regulatory style characterised by a 
tendency to control or avoid unpleasant internal experiences (including feelings, 
thoughts and physical sensations) [39]. A total score ranges from 15 - 90. A higher score 
is indicative of greater EA. BEAQ exhibited good internal consistency with Cronbach 
alphas ranging from .80 to .86 across clinical, community and student samples [10]. 
BEAQ also showed good test-retest reliability (r =.85) in a sample of chronic illness 




The Perceived Control of Asthma Questionnaire (PCAQ) [41] is an 11-item validated 
measure assessing individuals' perceived ability to manage their asthma. A total score 
ranges from 11-55, with a higher score indicating a greater perceived ability to control 
their asthma. In previous research using a sample of adults with asthma, the PCAQ 
showed good internal consistency (α = .79) and good construct validity [41]. The PCAQ 
also showed good internal consistency in the current sample (α = .83). 
Asthma-Specific Quality of life (QoL) 
Mini Asthma Quality of Life Questionnaire (MiniAQLQ) [42] is a validated 15-items 
tool measuring the impact of asthma on QoL in the past 2 weeks across the following 
four domains: asthma symptomatology, limitation of activities, emotions and 
environment. Total score ranges between 15 - 105. A higher score indicates a greater 
asthma-related QoL. In the development and validation study by Juniper et al. [42], 
MiniAQLQ showed good internal consistency with Cronbach alphas ranging from 
.80 to .89 for the total and individual domain scores, and a good ability to detect 
change over time. In the current sample, the internal consistency for the MiniAQLQ 
total score was α = .95. 
Asthma Control 
Asthma Control Test (ACT) [43] is a 5-item self-administered and validated 
questionnaire looking at individuals’ level of asthma control over the past 4 weeks. Total 
ACT score ranges from 5-25. In the analysis, the total score was used as a continuous 
variable where a higher score indicated a better asthma control. Scores  ≥20, 16-19 and 
< 16 indicate well-controlled, not well controlled and very poorly controlled asthma, 
respectively and were used in the current study to describe the sample. The ACT 
showed high internal consistency with Cronbach alphas ranging from .79 to .85 across 
studies using samples of adults with asthma attending asthma specialist clinic and 
subjects with both controlled and uncontrolled asthma [43,44]. ACT was also found 
to have good test-retest reliability (.77) [45]. ACT showed high correlation with other 
validated asthma control measure – Asthma Control Questionnaire (r = .89) [43]. The 




Data were also collected on various sociodemographic and asthma-related 
characteristics including participants’ self-reported age, gender, smoking status, BMI 
(calculated using reported height and weight), number of cigarettes smoked per day, 
number of years living with asthma, number of courses of steroid medication in the past 
year, short-acting reliever inhaler usage in the last week (defined as the number of 
inhalations in the last week), number of Accident and Emergencies (A&E) visits and 
hospitalizations in the past year. Smoking status was categorized to “never smoked”, 
“an ex-smoker”, “currently a smoker”. Courses of steroid medication were measured 
using the following 3 pre-specified categories “0”, 1-3” and “4 or more”.   
            Depression is a common co-morbidity in individuals with GA and was 
previously shown to be related to asthma morbidity. The Patient Health Questionnaire 
(PHQ-9) [46] is a validated tool assessing the severity of depressive symptoms. Total 
score ranges from 0-27. PHQ-9 demonstrated excellent internal consistency (α = .90) 
[46]. The Cronbach’s alpha for the current sample was .91.   
            Sociodemographic and asthma characteristics and levels of depression were 
assessed and included in the analyses as potential confounding variables.  
Data Analysis Plan 
 
All analyses were completed using the Statistical Package for Social Sciences (SPSS) 
version 24. SPSS EXPLORE, FREQUENCIES and DESCRIPTIVES  functions were 
employed to explore the sample characteristics and to report relevant descriptive 
statistics. Analyses using SPSS EXPLORE and REGRESSION function were used to 
evaluate relevant assumptions regarding normality. Pearson’s correlation coefficients 
were calculated to explore relationships between variables to a)  evaluate assumptions 
regarding multicollinearity, b) identify any covariates significantly associated with 
outcome variables and c) explore associations between predictor, mediators, and 
outcome variables.  
            Mediation analyses were conducted using the PROCESS Model 4 procedure for 
SPSS version 3.4.1 [47]. As recommended by Preacher & Hayes [48] a bootstrapped 
sampling distribution (based on 10,000 bootstrapped samples) was used to estimate the 
unstandardized indirect effects, the standard error and 95 bias-corrected confidence 
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intervals (CI) for the ‘ab’ mediation path. Since the bootstrapping method does respect 
the non-normal distribution of the indirect effect, it has been recommended to be used 
with smaller samples with more confidence [48]. The inference regarding whether the 
‘ab’ indirect effects are statistically significant will be evidenced by 95% bias-corrected 
bootstrap CI entirely above/below zero.  
            In separate mediation analyses, asthma morbidity indicators (asthma control, 
asthma specific QoL, SAARM use) were entered as outcome variables (y) and SE and 
EA as mediators (M). Generalize anxiety was entered as a predictor variable (x). The 
SAARM and steroid medication use and years living with asthma were entered as 
covariates in mediation models including asthma specific QoL and asthma control to 




























3.1. Recruited Sample  
 
Response rate post hoc power analysis 
 
A total of 203 eligible participants were identified by clinicians and were given a study 
pack to complete. Of those 65 participants have returned completed questionnaires, 
yielding a  32% return rate. This is in line with similar postal questionnaire studies 
conducted in adults with asthma [49]. Received questionnaires were screened and all 
responses were eligible for the inclusion in the study.  
          Post hoc analysis was conducted to explore power for the recruited sample (n=65). 
Given that mediation is based on regression analyses, we have calculated obtained 
power using the G power software. We have calculated that for four included regression 
models with 5 predictors (1 predictor, 1 mediator and 3 covariates), assuming medium 
effect the current sample reached the power of .62. The two regression models with 2 
predictors (1 predictor and 1 mediator) reached the power of .78. However, since the 
current study used a bootstrapping method which does respect the non-normal 





The sample (n = 65) had a low rate of missing data (.28%) with < 5% of data missing 
for any individual case. Two individual items were missing for outcome variables, with 
the remaining items (n = 12) missing for demographic variables. The Little’s Missing 
Completely at Random test showed that data for each variable were missing completely 
at random (MCAR), except for weight which was missing at random (MAR). Given that 
the current sample had < 25% of item scores missing in <10% of data, a single 
imputation (SI) method, namely Bayesian Stochastic Regression Imputation (BSRI) to 
item scores was used to deal with missing data [50]. This method was chosen over 
Complete Case analysis to preserve the variability of data and statistical power. The 
BSRI method to item scores was chosen over the multiple imputation as it previously 











When dividing variables by their standard error for skewness and kurtosis all 
independent and outcome variables showed to be approximately normally distributed 
with skewness and kurtosis values within acceptable ranges (approximately +/- 1.96 
for z score at p =.05) [55]. The Multicollinearity between predictor and demographic 
variables were assessed in SPSS by checking the variance inflation factors (VIF) and 
tolerance statistics. It was previously suggested that in smaller samples variables with 
VIF > 2.5 and tolerance < .2 are indicative of multicollinearity and should be assessed 
further [55]. All variables except for PHQ-9 and GAD-7 showed low VIF values 
(range between 1.1 and 1.6) and a tolerance >.2. suggesting no presence of 
multicollinearity. PHQ-9 and GAD-7 had higher VIF value of 3.1 and 2.6 
respectively. These variables also showed to be highly intercorrelated (r = .8, p < 
0.001) with a small Eigenvalue of .05 and .009, respectively. Removing highly 
correlated questionnaire item from PHQ-9 did not result in a reduction in 
multicollinearity. PHQ-9 was therefore removed from further analyses due to 
multicollinearity concerns. Removing PHQ-9 reduced VIF for GAD-7 to 1.8. Lastly 
exploring of scatterplots of residuals showed that all variables in the sample were 
approximately heteroscedastic. 
 
Correlational analysis  
 
The correlations between sample characteristics and study variables can be seen in 
table 2.5. The analysis identified significant associations between the hypothesised 
predictor - GA (GAD-7) and all hypothesised outcome variables: asthma control 
(ACT), asthma QoL (MiniAQLQ) and SAARM use. These were in expected direction. 
Greater anxiety was significantly correlated with poorer asthma control (r=   -.428** , 
p < .001), poorer asthma related QoL (r = -.540**, p < .001) and higher use of SAARM 
(r=  .412** ,p=.001 ). Significant correlations were also found between GA and both 
hypothesised mediators: EA (BEAQ) (r=.565**, p < .001) and SE (PCAQ) (r= -.525**, 




            Hypothesised mediators were then found to be significantly correlated with 
asthma control and asthma QoL in the expected direction. Greater EA (BEAQ) was 
associated with poorer asthma control (ACT) (r = -.406** , p = .001) and poorer asthma 
QoL (MiniAQLQ) (r = -.519**, p<.001). Greater SE to control asthma (PCAQ) was 
linked to better asthma control (ACT) (r = .498** , p<.001)  and QoL (MiniAQLQ) 
(.634**, p<.001). Greater PCAQ was associated with higher SAARM use (r = -.367, p 
= .003).  BEAQ was positively correlated with SAARM use in the expected direction 
but this association was just below a cut off for statistical significance (r = .024, p = 
.057). However, as per recent recommendations, the pattern of significance for 
individual ‘a’ and ‘b’ mediation paths does not necessarily indicate whether the 
indirect effect is significant [56]. The BEAQ will, therefore, be further explored as a 
mediator on the relationship between GA and SAARM to estimate the indirect effect.  
The SAAMR and steroid medication use and years living with asthma were 
significantly associated with both ACT and MiniAQLQ and were included as 












The first aim of the present study was to explore the relationship between GA, asthma 
control SE, EA, and asthma morbidity outcomes (asthma QoL, asthma control and 
SAAMR use) within a clinical sample of adults with asthma. In line with our 
hypotheses, the findings from the present study indicated that individuals with higher 
levels of GA presented with higher levels of EA, lower SE to manage their asthma and 
with poorer asthma morbidity outcomes. These included lower self-reported asthma 
control, asthma specific QoL and higher use of SAAMR use.          
          The link between higher levels of GA and lower asthma specific SE as well as 
asthma QoL and asthma control were in line with previous research in asthma 
population [6]. The found association between GA and EA was also consistent with 
results reported in the research literature from non-chronic health population [11-13], 
adding to the evidence base of EA in the asthma population. Our findings linking 
higher levels of EA with poorer asthma control and QoL were in line with research 
evidence from other chronic illnesses such as diabetes and HIV [14,15,16,17]. 
However, the majority of these studies used the AAQ questionnaire to measure EA 
which was previously widely criticised for its poor psychometric properties [27-29]. 
The current study was able to replicate these findings using BEAQ as a measure of 
EA. The BEAQ measure showed excellent reliability in the current sample. To our 
knowledge, this is a first study using BEAQ in a clinical sample of adults with asthma. 
It presents preliminary evidence of its usefulness as an alternative measure of EA.  
          In our study, higher EA was not linked to poorer medication compliance (as 
indicated by higher SAARM use), which was previously hypothesised based on 
findings from studies using samples with other chronic health conditions [14,15]. 
However, previous studies often focused on maintenance medication, and EA may 
have a different role when a relief medication is considered. It was initially 
hypothesised that individuals with higher EA are more likely to use higher doses of 
relief medication due to their lower tolerance of unpleasant asthma symptoms and 
tendency to cope with these by avoiding them. The fact that individuals with higher 
anxiety reported higher SAARM use, suggests that individuals might be misusing 
SAARM as a direct response to higher anxiety symptoms. Anxiety symptoms might 
be misperceived by individuals as asthma exacerbations. Higher SAARM might then 
be a direct attempt to manage a perceived health threat. It was previously suggested 
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that fear appraisals are faster and more automatic than appraisals related to unpleasant 
emotions which are likely to rely more on cognitive function and happen later in the 
process [58]. It is therefore likely that threat appraisals might happen independently 
and influence health behaviours differently. However, it is also possible that different 
variables not addressed in our study might play an indirect role. More research is 
needed to explore additional underlying mechanisms which might explain how GA 
influences higher SAAMR use.  
                        As hypothesised, EA and SE mediated the relationship between GA and 
both asthma control and asthma QoL. This effect persisted after the potential 
confounding effect of steroid use, SAARM use and years living with asthma were 
controlled for.  
            One possible explanation for the mediation path from increased GA to 
decreased asthma control through increased EA is that individuals with higher GA tend 
to experience more unpleasant internal sensations (worries and associated unpleasant 
physical symptoms), have a greater tendency to evaluate these sensations as aversive 
and engage in avoidance to regulate these. Greater tendency to employ EA has 
previously been shown to further increase the frequency and intensity of suppressed 
internal experiences and intensify their emotional, cognitive, and physiological impact 
[e.g. 18-20]. This reciprocal relationship between anxiety and EA is likely to lead to a 
prolonged cycle of avoidance effort which depletes cognitive, attentional, and 
emotional resources needed to make appropriate behavioural choices and maintain 
goal-directed self-management behaviours [21]. Self-management behaviours, and 
required self-control, might in themselves trigger increased anxiety and be perceived 
as aversive. EA might result in adopting short term relieve alternatives or to avoid self-
management behaviours altogether [22,23]. It is suggested that EA as a behavioural 
mechanism results in poorer self-management of asthma which is reflected in poorer 
control of asthma symptoms.  
          Since many of the same self-regulatory processes are needed to maintain valued 
activities, greater tendency to employ EA in individuals with higher anxiety is also 
likely to result in more restrictive lifestyle choices which impact on individual’s 
asthma-related QoL. It is also important to note that due to the overlapping concepts 
in the ACT and MiniAQLQ measures, adequate control of symptoms is also likely to 
positively influence ones QoL scores, which rely on domains such as activities, social 
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roles and asthma-related restrictions which are all impacted on the experience of 
asthma symptoms and how well controlled they are. 
       A possible explanation for SE as a mechanism to explain how higher anxiety can 
lead to poorer asthma control might lie in the pervasiveness of GA symptoms which 
might often mimic and be misinterpreted as asthma symptoms as well as directly 
impact on asthma. In individuals with anxiety, this can lead to continuous negative 
feedback related to one’s efforts to control their asthma. Such experience can 
undermine individuals perceived confidence in their ability to manage their asthma 
symptoms but also the usefulness of current self-management behaviours and health 
advice [59]. This can potentially decrease their motivation to engage in such 
behaviours (e.g. poorer compliance with medication regimens, etc., avoidance of 
asthma triggers, etc.), impacting on asthma control and QoL. Low SE has previously 
shown to be a well-established factor in the research literature associated with poor 
asthma control and asthma QoL [e.g. 6].  
           Despite findings in the general literature that individuals with higher levels of 
GA reported lower asthma control SE and higher EA [6, 11-13] and the evidence that 
lower asthma specific SE and EA correlates with poorer medication compliance 
including higher use of SAARM [6, 14,15] neither SE nor EA mediated the 
relationship between GA and SAARM. These results suggest that contrary to our 
hypothesis, in adults with asthma, GA only had a direct impact on SAARM, with 
increased levels of anxiety associated with higher SAARM use.  
 
4.1. Limitations and future directions 
 
Several limitations need to be considered when appraising the findings. First, due to 
the use of a cross-sectional design, no assertions can be made regarding causality in 
the observed relationships. Further research should employ prospective, longitudinal 
designs to examine whether improving  SE skills and decreasing EA leads to 
improvements in asthma control and asthma QoL in adults with asthma and comorbid 
anxiety. These could also inform us whether having consistently low SE and high EA 
plays a specific role in the maintenance of poor asthma outcomes with regards to 
asthma control and asthma QoL. The study relied exclusively on a questionnaire 
design and self-report, which could have potentially introduced bias due to poor recall, 
concerns about confidentiality and social desirability and fatigue/poor concentration 
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completing measures. Where possible authors tried to reduce some of these biases by 
assuring participants about confidentiality and anonymity and by giving participants 
time to complete questionnaires in their own time. The effort to complete 
questionnaires could have also potentially discouraged participants with certain 
characteristics. 
            Finally, calculating adequate sample size to detect indirect effects is complex 
and more research is needed [35]. The current study calculated its sample size on the 
assumption that it would be adequate for multiple regression analyses, given that 
mediation is based on regression. What more, by using the Bayesian bootstrapping 
method which does not rely on the assumption of normality, findings from the 
employed sample, although relatively small, can be interpreted with more confidence. 
However, given the limited knowledge that currently exists regarding mediation power 
calculations, there remains a possibility that the current study was underpowered to 
detect significant indirect effects employing the current statistical technique used.  
            To limit participants burden, information about potentially important sample 
characteristics such as ethnicity were not collected. Individual’s socio-cultural context 
has shown to be important in forming cognitions, beliefs and values regarding 
emotions and ways of expressing and coping with them [60]. Therefore, these are 
likely to moderate the relationship between GA, EA, and asthma outcomes. Future 
research should explore whether the relationship between anxiety, EA and asthma 
outcomes vary as a function of different socio-cultural context and beliefs. There also 
might be a weaker relationship between EA and asthma outcomes in individuals who 
have a wider range of “adaptive” strategies to regulate emotions. Future studies could 
employ more sophisticated models to investigate the effect of several emotion 
regulation strategies simultaneously.  
         Our study employed a clinical sample of NHS outpatients recruited from a 
secondary care respiratory and asthma specific clinics. These patients have typically 
more severe asthma and more complicated treatment regimens than samples drawn 
from the general population or primary care settings. This is likely to impact on their 
level of anxiety as well as influence their self-management behaviours and ways of 
coping with their emotions. Therefore, caution needs to be taken when applying our 
findings to samples from other settings. Further research employing samples of adults 
with asthma from additional clinical and non-clinical settings are needed to see if 
findings from the current study can be replicated in a wider asthma population. 
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However, given the link between the severity of asthma and anxiety, it is likely that 
our findings will be especially helpful for clinicians working with individuals with 
more severe or poorly controlled asthma.  
           Our sample also reported living with asthma for a long time (on average 26.3 
years). Although the current study has controlled for the effect of this variable in the 
analyses, living with asthma longer can likely affect the relationship between anxiety, 
SE, EA, and asthma outcomes. Future research could explore the role of anxiety, SE, 
and EA in individuals at different stages of their asthma journey, e.g. I newly 
diagnosed adults.  
          Although steroid and SAARM use were controlled for in the analysis as 
indicators of asthma severity, these relied on self-report. Future studies could control 
for objective indicators of asthma severity such as lung function or use electronic 
momentary assessment devices to report SAARM use.  
          Despite the preliminary support for the importance of SE and EA as underlying 
mechanisms to explain the link between GA and asthma QoL and asthma control, it is 
important to note that these reflect only a small subset of potential psychological 
mechanisms. In recent research with adults with other chronic illnesses, it was 
suggested that factors such as self-regulation and illness representation present 
additional psychological factors which might account for variance in illness-specific 
outcomes in adults [61]. Future research is needed to explore these further in adults 
with asthma with co-morbid anxiety. Future studies which compare the role of GA 
compared to health anxiety would be of interest to see if they influence asthma 
outcomes differently or through different mechanisms.  
 
4.2. Clinical implications 
Notwithstanding these limitations, few studies have examined the relation of anxiety 
disorders to later physical health symptoms, or the processes that may explain this 
relation. The current study is the first to explore SE and EA as potential mechanisms 
linking anxiety and asthma outcomes within a clinical sample of adults with asthma in 
NHS Scotland settings. These findings add to existing research on the link between 
psychological factors and asthma morbidity by showing that EA and SE constitute a 
vulnerability factor for poorer asthma outcomes in adults with anxiety. These results 
hold significant implications for our understanding regarding specific intervention 
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components which might be beneficial to promote better asthma outcomes in this 
population.  
            Considering these results, when higher levels of GA are identified in 
individuals with asthma, including a routine measure of EA and SE in clinical practice, 
may be particularly beneficial to detect individuals at risk of developing poorer asthma 
outcomes. Brief, self-report measures such as those included in the current study are 
often free, quick to administer and complete. Similarly, a preventative approach which 
includes clinicians asking about patterns of EA and SE in individuals with higher 
anxiety levels can promote positive changes through discussion or through redirecting 
patients towards helpful practical support and resources. Since it has been suggested 
that coping with anxiety using EA can deplete individual’s self-regulatory resources 
to self-management, where higher anxiety or EA is indicated clinicians should be 
mindful of simplifying self-management regimens where possible to reduce self-
regulatory load. Supported self-management, written treatment plans and follow up 
telephone consultations could also lessen the impact of anxiety and EA on asthma 
symptoms 
          Our results are also in line with existing research on the treatment of GA, which 
emphasises the negative impact of avoidance as a strategy to cope with difficult 
internal experiences [11-13]. It is now well established that continuous use of 
avoidance often intensifies the experience of difficulties and play an important role in 
their maintenance [11-13]. Our results provide preliminary, empirical support for the 
utility of psychological interventions among adults with asthma with co-morbid 
anxiety which specifically focuses on EA as a treatment component to improve asthma 
outcomes. These include for example cognitive-behavioural therapy (CBT), 
Acceptance Commitment Therapy (ACT) and Mindfulness-based interventions.  
         For example, Cognitive behavioural therapy might help individuals to identify 
unhelpful beliefs associated with their tendency to avoid their internal experiences and 
to test these assumptions through behavioural experiments. This would help 
individuals to challenge their positive beliefs about the usefulness of avoidance and 
reduce their reliance on it to regulate emotions. Alternatively, components of ACT or 
Mindfulness-based interventions focusing on fostering non-judgmental awareness and 
acceptance of internal experiences might help individuals developing skills to stay 
present with them without negative judgement. This can facilitate the re-evaluation of 
previous assumptions and foster more functional coping to improve asthma outcomes. 
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ACT and mindfulness interventions have been found to mediated therapeutic 
outcomes for individuals with chronic conditions such as diabetes, epilepsy, chronic 
pain, cancer [25]. Some preliminary findings showed that psychological interventions 
targeting EA led to improved self-management behaviours in chronic health 
conditions such as diabetes [24,25]. CBT was found to improve asthma outcomes such 
as asthma control and asthma QoL in adults and adolescents with asthma [62]. 
However, further research is needed to evaluate these interventions in asthma patients, 
specifically targeting EA as a mechanism of change.  
          The role of self-management SE on illness outcomes in asthma and other chronic 
illness has been well established. This is reflected in current interventions which 
emphasise the importance of promoting illness-specific SE skills for managing illness 
[63]. The current study added to the SE evidence base by highlighting its role as a 
potential mechanism which links higher anxiety with poorer asthma outcomes. It 
suggests that interventions which might help individuals to distinguish between their 
triggers for asthma exacerbations and triggers for anxiety might help patients to feel 
more confident in their self-management skills and improve their SE. Regular 
feedback to patients regarding their asthma management, highlighting small successes 
and fostering a sense of ownership for their self-management might also promote 
higher confidence in managing asthma in adults with anxiety [63] Helping patients to 
learn how to self-monitor their asthma and encourage them to keep records of their 
management (e.g. self-monitoring diaries or goal-setting plans) might assist them in 
receiving regular feedback for their self-management [63,64]. Such feedback might be 
protective against the diminishing of their asthma control SE due to the negative cycle 
of asthma and anxiety.  
            Findings from our study suggest that interventions targeting anxiety (physical 
symptoms and anxious cognitions) directly might be beneficial to address high 
SAARM use.  
          
5. Conclusions  
The results from the present study suggest that individuals’ asthma control SE and 
levels of EA mediate the relationship between GA and both asthma control and asthma 
QoL. These findings provide support for the utility of psychological interventions 
targeting SE and EA as important mechanisms of change to improve control of asthma 
symptoms and QoL in adults with asthma with co-morbid anxiety. These preliminary 
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findings also highlight that consideration of psychological co-morbidity in the asthma 
population is crucial as these have shown to be significantly associated with poorer 
asthma outcomes. The current study employed a clinical sample of adults with asthma 
receiving care from NHS outpatient respiratory services the results might be 
particularly relevant to clinicians working with individuals with more complex asthma 
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APPENDIX AA: Description of Emotion regulation strategies (adapted from 
Aldao et al. 2010 and Marroquin et al. 2017) 
 
Acceptance 
• Recognising the existence of a problem/stressor and allowing 









• Strategy to mentally escape, minimise or distract oneself from 
situational demands.  
• Disengagement from the problem or stressor, giving up efforts 
to actively cope with the problem/situation.  
• Not acknowledging the existence or importance of the current 




• Passive, repetitive, abstract thinking style focusing on the 
causes and consequences of one’s negative internal 
experiences. 
•  Passive, recurrent and pervasive thinking style focusing on 
possible future scenarios/ negative outcomes of 





• Efforts to restrain or control verbal and non-verbal expressions 
of emotion experience. 








• A cognitive strategy which reconstructs the meaning of a 
situational demand or a problem as having a positive quality. 
• Mentally changing the initial response to a stressor (e.g. 
























APPENDIX A: EMBASE, PsychINFO, PsychARTICLES and MEDLINE search 





Health condition of interest 
#1 "Asthma" OR “asthma*” 
Emotion regulation strategy 
#2 "emot* regulat*" OR "emot* dysregulat*" OR “avoid*” OR “ruminat*” OR 
“reapprais*” OR “accept*” OR “suppress*” OR "problem solv*" OR 
"problem-solv*" 
Asthma control outcomes 
#3 “asthma quality of life” OR “asthma-related quality of life” OR “asthma-
specific quality of life” OR “AQL*” OR “AQoL*” OR “quality of life” OR 
“LWAQ” OR “Living with Asthma Questionnaire” OR “St. 
George's Respiratory Questionnaire” OR “SGRQ” OR “asthma control” 
OR "self-manag*" or “self manag*” OR “adheren*” OR “nonadheren*” 
OR “non-adheren*” OR “complian*” OR “noncomplian*” OR “non-
complian*” 
Exclusion terms 




(#1 AND #2 AND # 3) NOT (#4) 
Total with limits 
#6 [limit #6 to (English or Czech language and articles published between 
1985 – 2019)]  
“asthma quality of life” OR “asthma-related quality of life” OR “asthma-specific quality of life” OR 
“QoL*” OR “HQoL*” OR “H QoL*” OR “HRQoL*” OR “AQL*” OR “AQoL*” OR “LWAQ” OR “SGRQ” 
OR “asthma control” OR "self-manag*" or “self manag*”OR “adheren*” OR “nonadheren*” OR 
“non-adheren*” OR “complian*” OR “noncomplian*” OR “non-complian*” 
 
 
APPENDIX B: Data extraction form 
 
Publication details (author, year, and country) 
Study design  
Sample characteristics (population, age, gender, sample size) 
Type of emotion regulation strategy and measure used 
Primary and Secondary Outcomes and measures used 
Statistical analysis  
Correlation coefficient (r) or equivalent between relevant variables 

















APPENDIX D: Modified Downs and Black (1998) Quality Appraisal Checklist and 
scoring guide 
 
External validity Scoring 
1. Representativeness of sample - Was 
the sample recruited representative of 
the entire asthma population from 
which they were recruited? Question 
12 from the full checklist (Y=1, N/U=0) 
 
A point was awarded if the study identified the source 
population for patients and described how the patients 
were selected. Patients were determined to be 
representative if they comprised the entire source 
population, an unselected sample of consecutive 
patients, or a random sample (only feasible where a 
list of all members of the relevant population exists). 
Where a study did not report the proportion of the 
source population from which the patients are derived, 
the question was answered as unable to determine. 
Internal validity/bias  
2. Data dredging - If any of the results of 
the study were based on “data 
dredging”, was this made clear? 
Question 16 (Y=1, N/U=0) 
A point was awarded if no retrospective unplanned (at 
the outset of the study) subgroup analyses were 
reported. 
 
3. Appropriate statistical tests - Were 
the statistical tests used to assess the 
main outcomes appropriate? Question 
18 (Y=1, N/U=0) 
 
If the distribution of the data (normal or not) was not 
described, it was assumed that the estimates used 
were appropriate, and a point was awarded. No point 
was awarded for studies that reported qualitative or 
quantitative data without any form of statistical 
comparisons or if the statistical tests reported were not 
appropriate. 
4. Appropriate outcome measures – 
Were the main outcome measures 
used accurate (valid and reliable)? 
Question 20 (Y=1, N/U=0) 
A point was awarded if the primary outcome measures 
were thought to be valid and reliable (e.g., the number 
of physical therapy visits per chart report), regardless 
of whether reliability or validity was reported. A point 
was not awarded if at least one of the primary outcome 
measures in the study was not valid or reliable or if this 
information was not reported or could not be 
determined (i.e., a questionnaire without reported 
validity or reliability). 
Internal validity - confounding  
5. Adjustment for confounding 
variables - Was there adequate 
adjustment for confounding in the 
analyses from which the main findings 
were drawn? – Question 25 (Y=1, 
N/U=0) 
A point was awarded unless the effect of the main 
confounders was not investigated or confounding was 
demonstrated, but no adjustment was made in the 
final analyses 
Power  
6. Size and power - Did the study have 
sufficient power to detect a clinically 
important effect where the probability 
value for a difference being due to 
chance is less than 5%? Question 27 
(Y=1, N/U=0) 
A point was awarded if sample sizes were calculated 
* modified - A point was awarded if sample sizes were 
calculated and reported by authors and were deemed 
as having a sufficient power. If not reported power was 
calculated using G-power and point was awarded if 
power was larger than .70 with alpha set at 0.05, 















Types of study to be included 
Studies will be included if they provided data regarding the relationship between the following 
emotion regulation strategies: acceptance, avoidance, problem-solving, reappraisal, rumination 
and suppression and primary asthma control outcomes in adults with asthma. Experimental or 
intervention studies will be included if they reported a baseline correlation between a specific 
emotion regulation strategy and primary outcomes. Non-correlational studies or studies which did 
not report the correlation, regression or similar data (and authors could not be contacted/provide 
this information) will be excluded. Single-case studies and qualitative-design studies will be 
excluded. Dissertations, theses, poster presentation and conference abstracts will be included if a 
sufficient study information can be obtained through manual search or contacting authors. 
Studies which were not available in English or Czech will be excluded due to limited access to 
translation resources. Studies which measured a general emotion regulation score, without details 
regarding specific subscales will be excluded. 
Condition or domain being studied 
In this review emotion regulation has been conceptualized as conscious and unconscious 
processes through which individuals notice, make sense of and alter their emotional experiences 
(Bargh and Williams, 2007; Gross and Jazaieri, 201; Mauss, Bunge, and Gross, 2007). Using a 
classification of emotion regulation strategies used Aldao et al. (2010) meta-analysis, the current 
review will study: acceptance, avoidance, problem-solving, reappraisal, rumination and 
suppression. 
 
Clinician-diagnosed asthma. If there are not enough studies identified in the asthma population, the 
search will be widened to include other chronic respiratory conditions (e.g. COPD) which are also 
associated with higher rates of treatment non-adherence and poorer self-management will be 
included. 
Participants/population 
Inclusion criteria: Studies will be included if they involve adults (from any nationality) over the age 
of 16 years with a diagnosis of asthma. Studies addressing both adults and children will be 
considered if the data provided for adults are reported separately or if the mean age is 16 years 
and over. Exclusion criteria: Studies will be excluded from the systematic review if they involve 
adults who experience comorbid health conditions which may have influenced their memory such 
as dementia, Parkinson's disease. Studies which used adults with comorbid substance misuse 
difficulties will also be excluded as substances can act as a form of emotion regulation (e.g. 
experiential avoidance). 
Intervention(s), exposure(s) 
Studies will be included in the current review if they employed a validated measure of an emotion 
regulation strategy, in line with specific subscales detailed in a recent meta-analysis by Aldao et al. 
(2010). Studies including a measure of acceptance and avoidance will be included if these were 
defined to assess acceptance/avoidance of thoughts, emotions and physical sensations. These will 
include studies looking at experiential avoidance (defined as an avoidance of thoughts, emotions 
and physical sensations), emotion avoidance or avoidance based emotional coping and avoidance 
of cognitive processes (e.g. distancing, distraction, etc.). To be included in the current review, 
studies will also have to include at least one of the primary outcomes at baseline. 
 




- Physiological and self-reported indicators of asthma control (e.g. lung function, asthma control 
self-reported 
measures) 
- Asthma medication adherence 
- Asthma-related quality of life 
[85] 
 
Timing and effect measures 
At baseline. 
Additional outcome(s) 
- Hospitalization for asthma 
- Emergency room (A&E) utilization for asthma 
Timing and effect measures 
At baseline. 
Data extraction (selection and coding) 
The author (LM) will independently examine the search output and screen it by title and abstract. 
Using the outlined inclusion criteria, the full texts of potentially eligible studies will be retrieved and 
assessed for eligibility. The author will then extract data using an extraction form designed 
specifically for the review. Data on patient characteristics, emotion regulation strategy 
characteristics, study methods and outcome data will be retrieved. 
Risk of bias (quality) assessment 
The author (LM) will assess and appraise the quality of the included studies using the Downs and 
Black checklist (Downs & Black, 1998). This checklist will be adapted to appraise four areas of 
methodological quality: external validity, internal validity: bias, internal validity: confounding 
(selection bias) and power. Within these areas, six criteria will be considered for each selected 
study: (i) the representativeness of the study sample; (ii) the use and reporting of "data dredging" 
(iii) the appropriate use of statistical tests to assess outcomes; (iv) the appropriate use of outcome 
measures; (v) the adequate adjustments for confounding in the analyses from which the main 
findings were drawn; (vi) the sufficient power of the sample to detect clinically significant effects 
where the reported difference had less than 5% probability to occur by chance. A third of included 
studies will be randomly selected to be rated by a second reviewer (GOH). A disagreement between 
reviewers will be discussed and resolved by consensus. Selected articles will be rated according 
to whether they appropriately addressed (2 points), partially addressed (1 point) or did not 
address/unable to determine (0 points) each of the six criteria. A total score for each study will be 
calculated. 
Strategy for data synthesis 
Since methodological and statistical heterogeneity will likely preclude meta-analysis, the current 
review will employ quantitative narrative (descriptive) synthesis. It will be conducted by the main 
research (LM) and it will employ a three-stage narrative synthesis framework based on guidance 
for conducting narrative synthesis for systematic reviews by Popay et al. (2006). The synthesis will 
be an iterative process with the following stages overlapping: 
 
1. Developing a preliminary synthesis of findings of included studies. This will involve organising 
findings from included studies to provide an initial description of patterns across the studies, 
specifically focusing on the direction and strength of the relationship of different emotion regulation 
strategies to asthma control outcome variables. 
 
2. The above guidance will be used to explore relationships within and between studies and 
consider factors which might explain any heterogeneity in their findings, specifically in the direction 
and/or strength of the relationship between specified emotion regulation strategies and asthma 
control outcomes, drawing on the risk of bias assessments. Sources of potential heterogeneity may 
arise from study designs, populations, outcomes, contexts or study settings. 
 
3. Assessing the robustness of synthesis. This will involve the main researcher (LM) appraising (1) 
the quality, (2) the relevance of the focus and (3) the extent of contribution of evidence towards 
answering the research question concerning the strength and direction of the relationship between 





Analysis of subgroups or subsets: None. 
 
Contact details for further information: Lucie Michalova; s1687740@sms.ed.ac.uk 
 
Organisational affiliation of the review: University of Edinburgh; www.ed.ac.uk 
 
Review team members and their organisational affiliations: Ms Lucie Michalova. The University of 
Edinburgh; Dr Paul Graham Morris. The University of Edinburgh 
 
Type and method of review: Narrative synthesis, Systematic review 
 
Anticipated or actual start date: 10 August 2019; Anticipated completion date: 01 March 2020 
 
Funding sources/sponsors: The University of Edinburgh 
 
Conflicts of interest: None; Language: Czech, English; Country: Scotland; Stage of review: Review 
Ongoing 
Subject index terms status: Subject indexing assigned by CRD; Subject index terms: Adult; Anxiety; 
Asthma; Emotions; Humans 
Date of registration in PROSPERO: 31 October 2019; Date of publication of this version: 31 October 
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Piloting of the study selection process Yes No 
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Yorkshire & The Humber - Leeds West Research Ethics Committee 
NHSBT Newcastle Blood Donor Centre 
Holland Drive Newcastle upon Tyne 
NE2 4NQ 
 
Telephone: 0207 104 8086 






Dear Lucie Michalova 
 
Study title: Generalised anxiety and asthma morbidity: the 
mediating role of self-efficacy and experiential 
avoidance 
REC reference: 18/YH/0385 
Protocol number: CAHSS1807/04 
IRAS project ID: 235661 
 
Thank you for your letter of 9th December, responding to the Proportionate Review Sub-
Committee’s request for changes to the documentation for the above study. 
 
The revised documentation has been reviewed and approved by the sub-committee. 
 
We plan to publish your research summary wording for the above study on the HRA 
website, together with your contact details. Publication will be no earlier than three 
months from the date of this favourable opinion letter. The expectation is that this 
information will be published for all studies that receive an ethical opinion but should 
you wish to provide a substitute contact point, wish to make a request to defer, or require 
further information, please contact please contact hra.studyregistration@nhs.net 
outlining the reasons for your request. 
Under very limited circumstances (e.g. for student research which has received an 
unfavourable opinion), it may be possible to grant an exemption to the publication of 
the study. 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the application form, protocol and 




Conditions of the favourable opinion 
 
The REC favourable opinion is subject to the following conditions being met prior to 
the start of the study. 
 
Management permission must be obtained from each host organisation prior to the start 
of the study at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must 
confirm through the signing of agreements and/or other documents that it has given permission 
for the research to proceed (except where explicitly specified otherwise). 
Guidance on applying for HRA and HCRW Approval (England and Wales)/ NHS permission for 
research is available in the Integrated Research Application System, at www.hra.nhs.uk or at 
http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites (“participant identification centre”), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations. 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database. This should be before the first participant 
is recruited but no later than 6 weeks after recruitment of the first participant. 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment. We will audit the registration details 
as part of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is 
registered but for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required 
timeframe, they should contact hra.studyregistration@nhs.net. The expectation is that 
all clinical trials will be registered, however, in exceptional circumstances non-
registration may be permissible with prior agreement from the HRA. Guidance on where 
to register is provided on the HRA website. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied 












The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
• Notifying substantial amendments 
• Adding new sites and investigators 
• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light 




You are invited to give your view of the service that you have received from the 
Research Ethics Service and the application procedure. If you wish to make your views 
known please use the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance 
 
We are pleased to welcome researchers and R & D staff at our RES Committee 
members’ training days – see details at http://www.hra.nhs.uk/hra-training/ 
 
 








Dr Rhona Bratt Chair 
 
Email: nrescommittee.yorkandhumber-leedswest@nhs.net 
Enclosures: “After ethical review – guidance for researchers” 
 
Copy to: Ms Charlotte Smith 
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PARTICIPANT INFORMATION SHEET 
Study title: What psychological factors influence asthma outcomes?  
My name is Lucie Michalova. I’m doing a research study as part of my training course 
to become a Clinical Psychologist and I’m inviting you to take part in my study. Before 
you decide whether to take part, it is important you understand why I’m doing the 
research and what it will involve.  
Please take time to read the following information carefully to decide whether you 
want to take part. You might want to talk it over with others. If anything isn’t clear, or 
if you want to find out more, feel free to get in touch – my contact details are at the 
end of this form. This information sheet is yours to keep. 
What’s the study for? 
In recent years it’s become clear that psychological factors influence how well people 
fare with their asthma. Many people with asthma have generalised anxiety (frequent 
and uncontrollable worries about nothing in particular) and this linked to poorer 
asthma control, poorer asthma-related quality of life and the need to use asthma 
reliever medication more often. But the reason for this link is unclear. I’m interested 
in finding out whether a person feeling lacking confidence in managing their asthma 
and their ability to cope with unpleasant physical and emotional symptoms can 
explain how anxiety can lead to poorer asthma outcomes.   
I hope my study will give a better understanding of what psychological factors 
influence asthma outcomes and help to develop better asthma treatments.    
Why have I been invited?  
Because you are aged between 16 and 75 and go to the Outpatient Asthma Clinic. 
Everyone we ask to take part will also have a diagnosis of asthma, good spoken and 
written English and currently don’t have other chest problems other than asthma 
(e.g., chronic bronchitis, cystic fibrosis, chronic obstructive pulmonary disease, HIV-
related lymphocytic airway inflammation) which are more problematic. Through 
speaking to you and checking your medical file, the doctor/nurse who looks 
after your asthma identified you as a potential participant.  
Before you decide whether you would like to take part 
Please note that due to the nature of the study I can’t invite people who are currently 
having an episode of a serious mental illness e.g. psychosis, have a diagnosis of 
Study title: What psychological factors influence asthma outcomes?       Participant Information sheet V6 4 November 2019                Page 2 of 4 
fibromyalgia and/or are currently abusing substances (e.g. alcohol, drugs). Please only 
continue with the rest of the study pack if these do not apply to you. You can still take 
part if your circumstances change before the data collection period has finished on 
30/04/20. If you want to discuss why you can’t take a part, please feel free to contact 
me (Lucie Michalova) on the number below.   
What will I be asked to do if I decide to take part? 
If you are interested in taking part in this study, you will need to go through this 
information sheet and carefully read the information included. You can get in touch 
with me using the contact details below if you want to ask any questions about the 
study.  
If you do want to take part, we’ll ask you to open your study pack and read through a 
consent form. This says that you understand what the study involves, and you agree 
to take part in the study. If you agree to take part, we’ll ask you for some basic 
information about you and your asthma. After this, we’ll ask you to complete 6 short 
questionnaires about your anxiety, mood, asthma related quality of life, the way you 
manage emotions, your perceived confidence in managing asthma and questions 
about your current asthma management. This should take on average about 20 
minutes. You’ll only need to fill these questionnaires in once.  
You can complete the study pack in the hospital if you want and hand it to the 
reception staff - or take it home and send it back using the pre-paid envelope. This 
will make sure you have as much time as you feel you need to think about taking part 
in the study and ask any questions you might have. It will also allow you to fill in the 
questionnaires when it suits you. 
Do I have to take part?  
No, it is your choice.  Taking part is entirely voluntary. If you do decide to take part, 
you are still free to change your mind up until the point of sending out/returning your 
study pack. After that you can’t. This is because all the responses in the study packs 
are anonymous and once, we’ve got yours back, we can’t link you to your responses. 
If you decide not to take part, that will not affect the standard of care you get.  
What are the possible disadvantages and risks of taking part?  
Risks are minimal. The questionnaires have been used by other clinical and research 
teams. There is no evidence that completing the questionnaires will harm you. 
However, you may find some of the thinking and concentration tasks frustrating if you 
are not sure of the answers. You may also find filling in the questionnaires tiring and 
some questions may make you think about difficult experiences which could upset 
you. If you find some questions upsetting, you do not have to answer them. If you 
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become upset or concerned about your asthma or mental health, you can speak to 
your GP or a member of your clinical team.  
What are the possible advantages and benefits of taking part?  
After you’ve completed the questionnaires, you’ll be asked if you wish to be included 
in a prize draw to have a chance of winning one of two £50 gift cards of your choice 
(Amazon/Tesco/Boots/Sainsburys/ASDA/John Lewis). You may also feel that by taking 
part you’ll contribute to a greater understanding of psychological factors that 
influence how well people with asthma fare.  
Will my participation in this study be kept confidential? 
Yes. We’ll keep all the information confidential. We’ll comply with the strict laws 
which safeguard your privacy at every stage of the study.  
After you have completed the questionnaires, any identifiable information will be 
removed and replaced by a code. There will be a unique study number assigned to 
your questionnaires. Although some of the other researchers involved in the study 
might look at your data, they won't know it’s yours. 
If you tell us any information during the data collection stage of this study which 
indicated any risk of harm to you or other people around you, I will have to tell 
someone. This is to make sure that you and other people are safe. I will only speak to 
a qualified member of staff, usually your GP, but I would discuss this with you first.   
What happens when the study is finished? 
After completing the questionnaires, you’ll have the chance to tell me how taking part 
in the study was for you. You can also discuss your experience with one of your carers 
at the clinic if you like.  
After I have finished analysis, anonymised electronic data will be archived within the 
University of Edinburgh for 10 years from the end of the project, with a review then 
and every following 5 years to decide whether data should continue to be stored or 
whether it should be securely deleted. Anonymised questionnaires will be held 
securely in a locked filing cabinet within the NHS Tayside premise until the 
departmental guidelines deem it appropriate to destroy them.  
What will happen to the results of the research study?  
I’ll write them up as part of my course work and submit them to the University of 
Edinburgh as part of my training for my Doctorate of Clinical Psychology. I also want 
to get the results of this study published in an academic journal and present the 
results to interested groups and conferences to help clinicians across the world have 
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a better idea of different psychological factors influencing asthma outcomes. The 
results will be anonymised. This means that you won’t be named or identified. 
Can I find out the results of the study? 
Yes. You will be able to see the results from the study and any associated publications 
on the project website. Go to: https://www.wiki.ed.ac.uk/x/W_xlFQ. Hopefully this 
will be from May 2020.   
How can I find out if I won a prize? 
If you agreed to be included in a prize draw, you will be asked to keep your Prize draw 
number which you can find at the of the debriefing sheet. The Prize draw will take 
place on 29th May 2020. Winning numbers will be published on the project website:  
https://www.wiki.ed.ac.uk/x/W_xlFQ on the same day with details of how to get in 
touch to claim the prize. Winners will have until 30th June 2020 to get in touch. If you 
forgotten the link to the study website or don’t have access to the internet, please 
contact me on the number above.  
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people called a 
Research Ethics Committee. Yorkshire and the Humber – Leeds West Research Ethics 
Committee thinks my study is ethical. NHS management has also approved it.  
Contacts: 
If you have any further questions about the study, get in touch with me, Lucie 
Michalova via Linda Scott on: 01382 346160 or email:
If you would like to discuss this study with someone independent of the study team, 
please contact: Geraldine O'Hagan via Linda Scott on: 01382 346160 or email:  
If you wish to make a complaint about the study, please contact NHS Fife: Patient 
Relations Department, Room 104, Hayfield House, Hayfield Road, Kirkcaldy, KY2 5AH, 
Tel: 01592 648153, Email: patientrelations.fife@nhs.net  
or  
NHS Greater Glasgow and Clyde: Complaints Department, North East Sector Offices, 
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DEBRIEF SHEET 
Study: What psychological factors influence asthma outcomes? 
 
Thank you for participating in completing the questionnaires for the above 
study. We hope that you have found it interesting and have not been upset by 
any of the topics covered. 
 
However, if you have found any part of this experience to be distressing or you 
are concerned about your asthma/or mental health and you wish to speak to 
someone, please contact your GP or your clinical asthma team. There are 
also several voluntary and NHS organisations listed below that you can contact 
for an expert and confidential support or advice:  
 
Samaritans 
Confidential support for people experiencing 
feelings of distress or despair. 
Phone: 116 123  
(free 24-hour helpline) 
Website: www.samaritans.org.uk 
Breathing Space 
Free and confidential support and 
signposting service aimed at people who are 
feeling sad or depressed. 
Phone: 0800 83 85 87 
(Mon-Thu, 6pm to 2am;  
Weekend: Fri 6pm – Mon 6am) 
Anxiety UK 
Charity providing support for people 
experiencing anxiety. 
Phone: 03444 775 774 
(Mon-Fri, 9.30am-5.30pm) 
Website: www.anxietyuk.org.uk 
Rethink Mental Illness 
Support and advice for people living with 
mental illness. 




Emotional support, information and guidance 
for people affected by mental illness. 
SANEline: 0300 304 7000  
(daily, 4.30-10.30pm) 
Website: www.sane.org.uk/support 
Asthma UK Helpline 
Advice and information about asthma and 
asthma management. 
Phone: 0300 222 5800 
(Mon-Fri, 9am -5pm) 
Website: asthma.org.uk 
 
If you have any further questions about the study, please contact Lucie 
Michalova via Linda Scott on: 01382 346160 or email:  
This debrief sheet is yours to keep. 
THANK YOU FOR YOUR PARTICIPATION 
_ _ _ _ _  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
PRIZE DRAW    If you agreed to be included in the prize draw, please retain this slip or 
write down your Prize draw number and keep it somewhere safe.  The draw will take place 
on 29th May 2020 and the winning numbers will be published on the project website on 
the same day with details of how to get in touch to claim the prize. Winners will have until 
30th June 2020 to get in touch. 
My Prize draw number _______        Study website: https://www.wiki.ed.ac.uk/x/W xlFQ
Study title: What psychological factors influence asthma outcomes? 
Study Protocol V6 13 November 2019 
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Introduction 
Asthma is a long-term health condition which is caused by obstruction of the airways due to 
inflammation (Global Initiative for Asthma guidelines, 2009). Despite asthma being a condition 
that can be managed very successfully through self-management and medication, it is estimated 
that in the UK around 1200 people a year die because of asthma (Taylor et al., 2014) and more 
than 50% live with asthma which is poorly controlled (Braido et al., 2016). Poor asthma control 
was associated with worse outcomes with regards to mortality, asthma-related quality of life 
(QoL) and higher utilization of health services in UK sample of adult asthmatics (Braido et al., 
2016). This highlights the need for a better understanding of factors that hinder effective asthma 
control and QoL to reduce unnecessary asthma-related personal/economic burden and 
mortality.  
            In recent years it has become apparent that psychological factors can explain an 
important proportion of variance in asthma outcomes (Di Marco et al., 2010; Deshmukh et al., 
2007). Generalised anxiety (anxiety characterized by the presence of unspecified, frequent and 
uncontrollable worries) has shown to be particularly prevalent in this population compared to 
individuals without asthma diagnosis (Lavoie et al., 2011; Weiser, 2007). Higher levels of 
generalised anxiety have been linked to poorer asthma outcomes such as asthma control, 
diminished asthma-related QoL and higher use of health care utilization (Di Marco et al., 2010; 
Feldman et al., 2005; Lavoie et al., 2011). Despite these preliminary findings, limited number 
of studies have looked at the association between generalised anxiety and asthma outcomes and 
only a handful have investigated a range of asthma outcomes indicators within the same study 
(e.g. asthma control and asthma QoL) (e.g. Lavoie et al., 2011, Fernandes et al., 2010). This is 
crucial as an individual who reports stable and well-managed asthma might still experience 
poor asthma-related well-being (Deshmukh et al., 2007). 
            Also, most studies looking at generalised anxiety in asthma employed a diagnostic 
interview as a method of exploring co-morbid generalised anxiety disorder (GAD). Although 
a valid measure, it can be argued that it doesn't account for subthreshold levels of generalised 
anxiety, which are also likely to be clinically relevant with regards to asthma-related behaviours 
and outcomes. Using more general measure might be therefore useful to capture a variance in 
anxiety scores amongst individuals with asthma. Compared to diagnostic interview, a quick 
GAD screen measure is also more likely to be used in routine clinical practice, given current 
NHS economical and time pressures.   
            As mentioned above, previously published studies highlighted that paying attention to 
psychological factors such as anxiety in asthma population is crucial as it showed to be linked 
to poorer asthma outcomes (please see Di Marco et al., 2010 for a review). However, less is 
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known in the literature about the underlying mechanism which can explain this relationship. 
The association between anxiety and asthma outcomes is complex. As such, it is likely to be 
influenced by other factors which might co-occur with high anxiety and change or explain its 
association with asthma morbidity (a relationship known as mediation).  
 
One important factor that may partially explain the link between anxiety and asthma-related 
outcomes is individual's perceived ability to manage their asthma, construct known as self-
efficacy (Bandura, 1994). A previous study by Lavoie et al (2011) found that amongst 
individuals with asthma, higher levels of GAD were associated with lower self-reported self-
efficacy to manage asthma. Many studies found that low levels of asthma-specific self-efficacy 
were in turn associated with worse overall asthma control, greater frequency of short-acting 
reliever medication use and poorer asthma-related quality of life (Lavoie, 2008; Manusco et al. 
2010; Martin, 2009; Chen, 2010; Lavoie et al., 2010). However, to date, only one study has 
explored self-efficacy as a potential factor influencing the relationship between generalised 
anxiety and poor asthma morbidity.  
            Another potential factor which might offer an explanation about how generalised 
anxiety contributes to asthma outcomes is experiential avoidance (a tendency to cope with 
unpleasant internal experiences including emotions, thoughts and bodily sensations by trying 
to change or avoid them). Emotion-focused strategies such as avoidance have been shown to 
predict poorer health outcomes whilst acceptance and more active coping strategies have been 
shown to have a positive effect on illness-related outcomes (Lazarus & Folkman, 1984; 
Bombardier et al., 1990). It was previously indicated that individuals with generalised anxiety 
have a lower ability to regulate unpleasant internal experiences and are more likely to engage 
in experiential avoidance (Buhr and Dugas, 2012; Mennin et al., 2002).  
            Previous studies showed that individuals who scored higher on experiential avoidance 
were more likely to report poorer medication compliance and disease control in other chronic 
illnesses such as HIV and diabetes (Chartier et al., 2010; Weijman, Ros, & Rutten, 2005). 
Avoidance of internal experiences has also been repeatedly associated with worse well-being 
and health-related QoL (e.g. Hayes et al., 2004). Some preliminary research findings using an 
asthma population suggested that higher levels of experiential avoidance were shown to 
negatively affect self-reported asthma-related QoL (Stavrinaki et al., 2013; unpublished study). 
However, much of the research looking at experiential avoidance is limited using the 
Acceptance and Commitment Questionnaire (AAQ-I, Hayes et al., 2004; revised AAQ-II, Bond 
et al., 2011) widely criticised for its poor psychometric properties and discriminant validity 
(Chawla & Ostafin, 2007; Gámez et al., 2011; Wolgast, 2014).  
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            Despite previous research suggesting that affective regulatory processes should be 
considered as an important factor influencing the relationship between distress and health 
outcomes, no published study to date has explored whether high levels of experiential 
avoidance influence the relationship between levels of generalised anxiety and indicators of 
asthma morbidity in adults with asthma.  
            In order to address some of the gaps in previous research and literature and to further 
develop an evidence base for the role of psychological factors on asthma-related outcomes, the 
current study aims to investigate the direct relationship between generalised anxiety and asthma 
morbidity indicators (asthma control, use of reliever asthma medication, asthma QoL) in adults 
with asthma and whether individuals’ confidence in managing their asthma and their tendency 
to avoid unpleasant internal experiences mediate this relationship. The current study will also 
try to address previous methodological limitations by employing more recently developed Brief 
Experiential Avoidance Questionnaire (BEAQ) (Gámez et al., 2014) as a measure of 
experiential avoidance. This measure has shown good psychometrics and thus might represent 
a more suitable measure to address AAQ limitations. The current study will also employ a self-
reported measure of GAD (7-item Generalised Anxiety Disorder Questionnaire) to investigate 
its predictive validity in the sample of adults with asthma.  
 
We hypothesise that:  
(1) In adults with asthma, higher levels of co-morbid generalised anxiety will be associated 
with poorer asthma morbidity indicators (poorer asthma control, higher use of reliever asthma 
medication and poorer asthma quality life), lower self-efficacy to manage asthma and greater 
experiential avoidance. 
 
(2) In adults with asthma, Self-efficacy and Experiential avoidance will contribute to the 
explanation of the relationship between generalised anxiety and poorer asthma morbidity 





An opportunistic sample of 100 - 120 patients will be recruited from the outpatient asthma 
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Using G*power 3.0.10 (Faul, Buchner, Erdfelder & Lang, 2008), a priori power calculation 
estimated that employing a hierarchical multiple regression analysis with 6 control and 1 test 
predictors (total of 7 predictors), a sample of 89 participants will be required to detect a medium 
effect size (.15) with a power of .95 (alpha set at .05). The researcher will aim to recruit 100 -
120 participants to allow for a higher amount of attrition. This sample size was deemed enough 
for a subsequent mediation analyses using a bootstrapping approach. In accordance with 
recommendations by Fritz & MacKinnon (2007), it has been estimated that for this analysis a 
sample size of 71 will be required to achieve a power of 0.8 to detect a medium effect size of 




Identified by clinician:  
• Primary diagnosis of asthma 
• Aged 16 - 75 years 
• Receiving medical treatment for asthma for at least 6 months 
• Good written and spoken understanding of English language 
 
Exclusion criteria: 
Identified by clinician:  
• Diagnosis of a pulmonary disorder presenting higher morbidity than asthma (e.g., chronic 
cystic fibrosis, chronic obstructive pulmonary disease, HIV-related lymphocytic airway 
inflammation) 
• Apparent cognitive or language deficit 
 
Self-reported by participants: 
• Currently experiencing an episode of a serious mental illness, e.g. psychosis 
• Self-reported current misuse of alcohol or drugs 
• diagnosis of Fibromyalgia  
 
Identification of participants 
 
Eligible participants will be identified by their current respiratory clinicians (either respiratory 
consultants or respiratory nurses) working in the outpatient respiratory departments in NHS 
Fife and NHS Greater Glasgow and Clyde. Clinicians will be provided with the inclusion and 
exclusion criteria as well as information about the study and they will screen all potential 
participants to ensure that patients not meeting the study criteria are excluded. This will involve 
speaking to participants and checking their medical file. At the end of their routine consultation 
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session, clinicians will be asked to briefly discuss the current study with eligible participants 
and check their willingness to participate. If participants show a preliminary interest, the 
clinician will provide them with a study pack.  
            A first section of the study pack will include an information sheet about the study. This 
section will clearly state the rationale of the study, what it will entail and confidentiality 
guidelines. It will also screen participants for additional exclusion criteria: current alcohol and 
drug abuse, current episode of serious mental health difficulties e.g. psychosis and diagnosis of 
Fibromyalgia. These exclusion criteria will be self-reported as patient's might not feel 
comfortable to disclose these to clinicians due to stigma and might not be included in their 
patient file. If participants are excluded at this point and they wish to discuss this further the 
information sheet will advise them to contact the Chief Investigator on the contact details 
included. The information sheet will also make participants aware that participation is 
voluntary, their participation/non-participation will not affect the care they receive and that 
they can withdraw from the study at any point until the end of the data collection period. It will 
clearly state Chief Investigator's contact details if participants wish to discuss the study in more 
details prior to participation. To fully consider their participation, participants can decide to 
complete the pack at any time from receiving the pack until the end of the study.  
 
Questionnaires and consenting procedure 
 
In the research pack, potential participants will be told that they are being invited to take part 
in a research project about the impact of psychological factors on asthma outcomes. They will 
be informed that, should they wish to participate, they will be asked to provide some basic 
information about themselves such as age, gender and their asthma. After this, they will be 
asked to complete 6 short questionnaires about their anxiety, mood, asthma related QoL, the 
way they manage emotions, their perceived confidence in managing asthma and questions 
about their current asthma management. The completion of the questionnaires should take on 
average about 20 minutes. Potential participants will be advised that they will be asked to fill 
these questionnaires only once and they can choose to either fill them once in the hospital and 
return them to the reception or take them home and when completed post them pack in a prepaid 
envelope. They will be advised that they can take part at any point until the end of the study 
collection period. The last study packs will be distributed no less than one week before the end 
of the study collection period to give all participants at least one week to consider participation 
and to take part.  
            Before taking part, participants will be asked to carefully read the provided information 
sheet and decide whether they would like to participate. In the consent form, participants will 
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be asked to read statements that ensure that they read the information sheet, understand what 
the study involves and agree to take part. Only then, the participants will be asked to continue 
with the questionnaire part of the study pack. Participants will be made aware that if they decide 
to go ahead and complete and return the questionnaires, it will be assumed that they are giving 
their consent to take part. It is estimated that reading the information sheet and providing a 




A total of 100-120 patients who currently receive treatment for asthma will be recruited from 
the outpatient respiratory departments in NHS Fife and NHS Greater Glasgow and Clyde. 
Clinicians will identify participants from their current caseloads using provided inclusion and 
exclusion criteria. This will involve speaking to participants and checking their medical file, 
where this is necessary to confirm inclusion/exclusion criteria. Eligible participants who are 
willing to participate will be provided with a study pack. They will be asked to complete the 
study pack in their own time. Participants who read and understood the study information and 
associated consent form and decided to take part will be asked to provide basic demographic 
and asthma related information and 6 questionnaires. Selected measures were chosen with an 
intention of reducing unnecessary participation burden. Brief versions of measures were chosen 
were available. The completion of the following procedure is estimated to take around 20 
minutes in total. Participants will be asked to complete the questionnaires once only. 
 
The procedure will include the following: 
• The Demographic form which was developed by the researcher. The form collects basic 
demographic information, including participant's age, sex, height and weight (to calculate 
BMI), smoking status, number of cigarettes smoked/day and number of years living with 
asthma, short-acting reliever inhaler usage in the last week (defined as a number of inhalations 
in the last week), number of courses of steroid medication in the past year and number of A&E 
visits and hospitalizations in the past year. Average completion time: 3 minutes 
• The Generalised Anxiety Disorder 7 (GAD – 7) questionnaire (Spitzer, Kroenke, Williams 
& Löwe, 2006) which is a self-report questionnaire designed to assess the occurrence of anxiety 
symptoms in the last two weeks. GAD-7 showed to be internally consist (α = .92) and reliable 
(test-retest) (ICC = .83) (Spitzer et al., 2006). Participants are asked to rate their experience of 
anxiety symptoms on a 4-point Likert scale ranging from 0 = not at all to 3 = nearly every day). 
The total score is derived as the sum of scores (range 0 to 21). Scores can be divided into the 
following anxiety severity levels: mild = ≥ 5, moderate = ≥ 10 and severe = ≥ 15. A score above 
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10 has been used as a cut-off indicating the presence of anxiety disorder (Williams, 2014). 
Given the frequent overlap between anxiety and depression, a factorial analysis was conducted 
to assess GAD-7 alongside a measure of depression: Patient Health Questionnaire (PHQ-9) 
(Spitzer et al., 2006). All GAD-7 items showed highest factor loading on factor one compared 
to all depression items that showed the highest loading on factor two, demonstrating that GAD-
7 measures distinct construct from depression. Average completion time: 2 minutes 
• Patient Health Questionnaire (PHQ-9) (Spitzer et al., 1999). As depression is a common co-
morbidity in individuals with generalised anxiety and was previously shown to be related to 
asthma morbidity, the current study will examine levels of depression in the current sample. 
The PHQ-9 (Spitzer et al., 1999) is a 9-item self-report questionnaire and will be used to assess 
depressive symptoms. Sum of scores is used to obtain a total score (range 0 to 27). A higher 
score indicates a greater occurrence of depressive symptoms. PHQ-9 demonstrated good 
internal consistency (α = 0.90) (Spitzer et al., 1999). Average completion time: 2 minutes 
• The Perceived Control of Asthma Questionnaire (PCAQ) (Katz, Yelin, Eisner and Blanc, 
2002) will be used to measure individuals' perceived ability to manage their asthma. The PCAS 
is an 11-item self-report measure. Responses are scored on a 5-point Likert scale ranging from 
1 - strongly agree to 5 - strongly disagree. In previous research using a sample of adult 
asthmatics, the PCAQ showed good internal consistency (.79) and construct validity (Katz, 
Yelin, Eisner and Blanc, 2002). Previous studies have found an association between PCAQ and 
asthma-specific QoL (using mini Asthma-Specific Quality of Life Questionnaire) and asthma 
control (using Asthma Control Questionnaire) (Katz, Yelin, Eisner and Blanc, 2002; Olajos-
Clow, Costello and Lougheed, 2005). Average completion time: 3 minutes 
• Brief Experiential Avoidance Questionnaire (BEAQ) (Gámez et al., 2014) is a briefer 
version of the original well validated Multidimensional Experiential Avoidance Questionnaire 
(MEAQ) (Gámez et al., 2011). BEAQ consists of 15 items assessing experiential avoidance – 
defined as a coping style used to regulate unpleasant internal experiences (including feelings, 
thoughts and physical sensations) which ranges from acceptance to avoidance (Machell, 
Goodman & Kashdan, 2014). In the original evaluation study, BEAQ exhibited good internal 
consistency with Cronbach alphas ranging from .80 -.86 across clinical, community and student 
samples. What more, in a recent study using a sample of chronic illness population (patients 
with cancer) BEAQ showed good test-retest reliability (r = .85) (Carr, 2014).  Average 
completion time: 4 minutes 
• Mini Asthma Quality of Life Questionnaire (MiniAQLQ) (Juniper et al., 1999) is a shorter 
15-item version of the well-established and validated AQLQ (Juniper et al. 1992). It is designed 
to assess the impact of asthma on QoL across four domains in the past two weeks: asthma 
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symptomatology, limitation of activities, emotions and environment. Individuals are asked to 
rate their responses on a 7-point Likert scale (ranging from 1 = severe impairment to 7 = no 
impairment). In the development and validation study by Juniper et al. (1999) MiniAQLQ 
showed good internal consistency for the total and individual domain scores (.80 - .89) and a 
good ability to detect change over time. In a study using a sample of adults with physician-
diagnosed asthma, the MiniAQLQ showed Cronbach alpha of .90, .67, .84 and .94 for the 
symptoms, environment, emotions and limitation of activities subscales respectively (Avallone 
et al., 2011). Average completion time: 3 minutes 
• Asthma Control Test (ACT) (Schatz, 2006) is a 5-item self-administered and validated 
questionnaire looking at individuals’ level of asthma control over the past 4 weeks. Self-
reported items are rated on 5-point Likert scale ranging from 1=poor control to 5=good control. 
Total ACT score is obtained by summing up scores on all 5 items and ranges from 5-25. In the 
analysis, Asthma Control Test score will be expressed as a continuous variable where higher 
scores indicate better control. The 3 levels of ACT scores where ACT score ≥20 identifies 
well-controlled asthma, score 16-19 not well controlled and < 16 indicating very poorly 
controlled asthma, will be calculated to gain a better understanding about the sample. The 
ACT showed high internal reliability consistency (0.85) in a sample of adult asthmatics 
attending asthma specialist clinic (Schatz et al, 2006). Similarly, Nathan et al. (2004) reported 
high internal consistency of the ACT score with specialists’ ratings among subjects with 
controlled asthma as well as subjects with uncontrolled asthma (0.79 and 0.83, respectively). 
ACT was also found to have a good test-retest reliability (0.77) (Alvarez-Gutie´rrez et al., 
2010). ACT showed high correlation with other validated asthma control measure – Asthma 
Control Questionnaire (r = .89) (Schatz et al., 2006). Average completion time: 3 minutes 
The final section of the study pack will contain information about the aims of the study to 
ensure participants fully understood the purpose of their involvement. It will also contain Chief 
Investigator's contact details if participants wish to ask any questions regarding the study. It 
will outline that participants should contact their GP, current asthma team or 3rd sector 
voluntary organisations (list provided) if they become concerned about their mental health or 
asthma. The final page will thank participants for taking part in the study and provide a web 
link to a project wiki page (https://www.wiki.ed.ac.uk/x/W_xlFQ) which will have details of 
study results with an approximate timescale when these results will be available for viewing. 
Study results will be available in an easy to read standardised abstract format together with 
downloads for any suitable reports or other outputs such as publications.  
            It will also include information about a prize draw and ask participants to retain a slip 
including their allocated prize draw number or to write it down somewhere safe. Individuals 
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who participated before 20th December, the original end of the recruitment period, will be made 
aware that the prize draw will take place on 20th January 2020. The winning numbers will be 
published on the project wiki page (https://www.wiki.ed.ac.uk/x/W xlFQ) on the same day 
with details of how to get in touch to claim the prize. Winners will be made aware that they 
have until 20th February 2020 to get in touch. Participants will be advised that if they lost the 
details of the project website or do not have access to the internet, they can get in touch with 
the Chief Investigator using included contact details.   
           To reflect the extension of recruitment period from 21st December 2019 until the end of 
April 2020, participants who are recruited within this period, will receive updated study 
documentation and will be included in an additional prize draw which will include additional 
vouchers. The updated documentation will include details of the additional prize draw date 
(29th May 2020) and the deadline to claim the prize (30th June 2020). The additional prize draw 
will follow the same procedure as the previous one with regards to the type of prizes, publishing 






The group characteristics will firstly be reported. The proportion of male and female 
participants and participants who smoke will be calculated together with means and standard 
deviations for age, years of living with asthma, cigarettes smoked a day, BMI, frequency of 
A&E visits and hospitalizations in the past year, number of inhalations in the last week (short-
acting reliever inhalator usage). Additional descriptive statistics will be calculated in 
percentages for discrete demographic variables, including courses of steroid medication in the 
last year ('0', '1-3', '4 or more') and smoking status ('current smoker', 'ex-smoker', 'never 
smoked'). Means and standard deviations will be calculated for quantitative variables, including 
level of GA (GAD-7 score), depression (PHQ-9 score), experiential avoidance (BEAQ score), 
perceived control of asthma (PCAQ score), QoL (MiniAQLQ score), asthma control (ACT 
score).  
 
Exploratory analyses: the relationship between predictor and outcome variables 
 
Correlations will be calculated to explore relationships between predictor and outcome 
variables. The Pearson product correlation coefficient for parametric data or the Spearman's 
rank correlation coefficient for non-parametric data will be used to explore the strength of the 
relationship between the predictor and outcome variables. The absolute value of the correlation 
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coefficient will be taken to represent the following effect sizes: small for values >0.3, medium 
for values between 0.3-0.5 and large for values <0.5 (Cohen, 1988). Only variables that 
significantly correlate with the outcome variables will be included in subsequent regression 
analyses. 
The relationship between generalised anxiety and asthma outcomes 
 
To test the relative strength of generalised anxiety in predicting indicators of asthma morbidity 
at time 1 (asthma control, asthma-specific QoL and frequency of use of short-acting asthma 
reliever medication), a simultaneous forced entry linear regression model will be calculated for 
each outcome variable, yielding three models in total. The forced entry method allows to test 
the exploratory power for the hypothesised variable whilst controlling for other variables in the 
equation. This is a preferred method for making predictions for new models since it allows to 
weigh the relative contribution of each variable without making prior assumptions regarding 
their importance (Field, 2003). In each of these analyses, independent variables will be entered 
in the following order (steps): (Step 1) control variables (age, sex, BMI, number of cigarettes 
smoked/day, number of years living with asthma and PHQ-9 total score) will be entered first 
to control for their potential confounding effect, followed by a test predictor (generalised 
anxiety) (Step 2). Indicators of asthma morbidity (asthma control, frequency of short-acting 
acting asthma reliever medication and asthma-specific QoL) will be entered as dependent 
variables.  Analyses will be conducted using SPSS version 21 (IBM, Released 2012) or 
equivalent. 
 
The influence of self-efficacy and experiential avoidance on the relationship between 
generalised anxiety and asthma outcomes 
 
A series of mediation analyses (Preacher & Hayes, 2004) will be conducted using PROCESS 
macro MODEL 4 in SPSS (Hayes, 2013) or equivalent to investigate factors that were 
hypothesized to influence difference in asthma morbidity. Each of the mediation models will 
independently evaluate whether the relationship between generalised anxiety and indicators of 
asthma morbidity (asthma control, asthma-specific QoL, short-acting asthma reliever 
medication use) are influenced by individuals' perceived ability to manage their asthma and 
their levels of experiential avoidance.  
 
Direct and indirect effects will be reported with 95% confidence intervals (CI) and p-values 
and will be considered statistically significant at p-value <.05. Following recommendations by 
Preacher and Kelley (2011) mediation effect sizes will be reported as magnitudes of the indirect 
effects compared to the maximum possible indirect effects (k²) to better capture the full 
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meaning of indirect effects. According to Preacher and Kelley (2011) k² values of .1, .9 and .25 
will indicate small, medium and large effect respectively. The current study will also report 
standardised regression coefficients (B) (measure for "a" coefficient) and partial correlations 
(r) (measure for "b" coefficient) to provide an indicator of effect sizes which can be compared 
with results from previous studies (MacKinnon, Fairchild & Fritz, 2007). Following Cohen 
(1988), B values of .14, .36 and .54 and r values of .1, .3 and .5 indicate small, medium and 
large effect respectively for each value. Preacher and Kelly (2011) noted that it is deemed 
appropriate to report multiple formats of effect sizes within the same study. 
 
Application 
Given the serious and adverse consequences of poorly controlled asthma, it is of great 
importance to improve our understanding of different factors influencing asthma outcomes. 
Accumulating evidence suggests that psychological factors can explain an important 
proportion of variance in asthma outcomes in adults with asthma. Previous studies have shown 
that generalised anxiety is particularly frequent in adults with asthma and can influence 
differences in asthma outcomes. However, the link between these is poorly understood. 
Although some preliminary evidence suggests that self-efficacy and differences in the way 
people perceive and manage emotions can provide some explanation regarding this link, it is 
yet to be investigated. The present study aims to fill this gap in the current research to expand 
our understanding of the impact of different psychological factors on asthma outcomes.  
Findings from this study might encourage qualified professionals in asthma services to place 
more importance on taking psychological measures as part of the assessment process and on 
recognising how psychological factors might influence asthma-related outcomes. 
Psychological factors such as anxiety, self-efficacy and experiential avoidance are all 
modifiable factors which can be directly addressed through simple interventions. A better 
understanding of how these factors influence asthma morbidity can introduce an additional 
platform for asthma treatment, making it more effective. This could benefit asthma patient 
population as a whole by reducing the personal and physical burden of asthma and NHS 
services by reducing costs associated with poorly controlled asthma (e.g. increased medication 
use and greater health care utilization).  
Lastly, as psychological research in this population is scarce, it is hoped that the current study 
will inspire future projects which will continue to add to the current evidence base and to the 
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